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resumo 
 
 
Cardiolipina (CL) é um fosfolípido de estrutura complexa, que se encontra 
quase exclusivamente na membrana interna da mitocôndria, onde se encontra 
associada a diferentes complexos da cadeia respiratória. Pela sua localização, 
este fosfolípido desempenha um importante papel no metabolismo energético 
mitocôndrial. Alterações na cardiolipina nomeadamente por modificações 
oxidativas têm sido relacionadas com a apoptose celular e com várias 
condições patológicas, particularmente nas doenças neurodegenerativas. 
A estrutura da CL apresenta quatro cadeias de ácidos gordos que podem 
diversificar no comprimento e no grau de insaturação, é muito susceptível a 
danos oxidativos por espécies reactivas de oxigénio (ROS). A sua localização, 
na mitocôndria aumenta a probabilidade desta sofrer oxidação, uma vez que 
existe uma considerável produção de ROS na membrana interna mitocôndrial. 
ROS estão envolvidas no stress oxidativo em diferentes biomoleculas, 
nomeadamente nos lípidos, levando a modificações na sua estrutura e 
consequentemente, à perda da sua função. Apesar da importância da 
oxidação da CL e das suas possíveis consequências biológicas, existe um 
conhecimento limitado em relação aos produtos de oxidação formados em 
condições de stress oxidativo. 
Neste estudo, a espectrometria de massa e a espectrometria de massa 
acoplada à cromatografia liquida (LC-ESI-MS) foram utilizados para identificar 
modificações oxidativas especificas da tetra-linoleoil CL induzidas pelo radical 
hidroxilo através da reacção de Fenton (H2O2 and Fe2+). Os resultados obtidos 
neste estudo permitiram identificar pela primeira vez diversos produtos de 
oxidação de cadeia curta e também outros de cadeia longa durante a oxidação 
da CL. Os produtos de oxidação de cadeia curta resultam de uma clivagem do 
ácido gordo oxidado, conduzindo á formação de ácido gordos de cadeia curta 
com terminal aldeído, e ácidos dicarboxilico, observados em MS na forma de 
iões [M-H]- e [M-2H]2-. Estes resultados permitiram detectar alguns destes 
produtos de oxidação na mitocôndria dos rins dos ratos tratados com 
gentamicina, com nefropatia confirmada.    
A identificação detalhada da fragmentação dos produtos de cadeia longa por 
LC-MS/MS permitiu a diferenciação de isómeros, e a identificação do local de 
oxidação para CL com 2, 4, 6 e 8 átomos de oxigénios. Este trabalho permitiu 
identificação de iões produto específicos que permitem a sua atribuição 
inequívoca, que será fundamental para a identificação destas espécies em 
amostras biológicas. 
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abstract 
 
Cardiolipin (CL) is a phospholipid with a complex structure, found almost 
exclusively in the inner mitochondrial membrane, where it is found associated 
with several different complexes of the respiratory chain. Because of its 
localization, this phospholipid performs an important role in the mitocôndrial 
energetic metabolism. Alteration of CL namely by oxidative modifications has 
been related with various pathological conditions, particularly in 
neurodegenerative diseases. 
CL structure bears four chains of fatty acids that can diversify in length and 
degree of unsaturation; it is susceptible to oxidative damage by reactive oxygen 
species (ROS). Their location, in the mitochondria, makes them even more 
likely to be oxidized, since that there is a considerable production of ROS in the 
inner mitochondrial membrane. ROS are involved in oxidative stress 
modifications of different biomolecules, namely lipids, leading to changes in 
their structure and in consequence, loss of their function. In spite of the 
importance of CL oxidation and it biological consequence, there is a limited 
knowledge of the oxidation products of CL formed under oxidative stress.  
In this study, mass spectrometry and mass spectrometry coupled with liquid 
chromatography (LC-MS) was used to identify the specific oxidative 
modifications of tetra-linoleoyl CL induced by the hydroxyl radical generated 
under Fenton reaction conditions (H2O2 and Fe2+). The results obtained with 
this study allowed us to identify, for the first time, several short chain oxidation 
products along with some long chain products during the oxidation of CL. 
Short-chain oxidation products resulted from a cleavage of the oxidized fatty 
acid, leading to the formation of short chain fatty acids with aldehyde terminal, 
and dicarboxylic acids, observed in MS in the form of the ions [M-H]- and [M-
2H]2-. These results allowed us to detect some of these oxidation products in 
the mitochondria of kidneys obtained from rats treated with gentamicin, with 
confirmed nephropathy.  
The detailed identification of the fragmentation of the long chain products by 
LC-MS/MS allowed us to differentiate isomers, and the identification of the 
oxidation location for the CL with 2, 4, 6 and 8 oxygen atoms. This work 
allowed the identification of specific product ions which allow their unequivocal 
assignment that will be paramount for the identification of these species in 
biological samples. 
 
 Index 
 
Chapter I 
Introduction .................................................................................... 5 
1. Phospholipids .............................................................................. 6 
2. Cardiolipin .................................................................................. 8 
2.1. Structure chemical and biosynthetic pathways ........................... 8 
2.2. Cardiolipin acyl chain composition and subcellular distribution .... 10 
2.3. Cardiolipin and mitochondria .................................................. 10 
2.3.1. Interaction with mitochondrial proteins ............................. 11 
2.3.2. The interaction of CL with cytochrome c and its role in 
apoptosis ................................................................................. 12 
2.3.3. CL and disease .............................................................. 13 
Barth syndrome .................................................................. 14 
Thyroid dysfunction ............................................................. 14 
Diabetes ............................................................................. 15 
Tangier disease ................................................................... 15 
Aging ................................................................................. 15 
Neurodegenerative disease ................................................... 16 
2.4. Cardiolipin oxidation .............................................................. 16 
3. Experimental approaches in Lipidomics research ............................. 20 
3.1. Separation methods .............................................................. 20 
3.1.1. Thin layer chromatography .............................................. 20 
3.1.2. High-Performance Liquid Chromatography ........................ 22 
3.2. Mass spectrometry ................................................................ 23 
3.2.1. Ionization source ........................................................... 24 
Electrospray (ESI) ............................................................... 24 
MALDI ................................................................................ 25 
 3.2.2. Analyzers ...................................................................... 26 
Linear Ion trap .................................................................... 26 
Quadrupole ......................................................................... 27 
Time of flight ...................................................................... 27 
3.2.3. Tandem Mass Spectrometry (MS/MS) ............................... 27 
4. Mass spectrometry in the analysis of cardiolipin ............................. 29 
5. Aims ......................................................................................... 31 
6. References................................................................................. 32 
 
Chapter II 
Cardiolipin and oxidative stress: Identification of new short chain 
oxidation products of cardiolipin in in vitro analysis and in 
nephrotoxic drug-induced disturbances in rat kidney tissue .......... 41 
 
Chapter III 
Liquid chromatography tandem mass spectrometry analysis of long 
chain oxidation products of cardiolipin induced by the hydroxyl 
radical ........................................................................................... 71 
 
Chapter IV 
Conclusions ................................................................................... 91 
 
  
  
CHAPTER I 
Introduction 
Introduction 
 
5 
 
Introduction 
Lipidomics is an emerging field that is dedicated to the analysis of lipids 
from a biological sample, such as tissue, cells, biological fluids, among 
others. This methodology helps in the study of lipids, their changing in 
response to different stimulus or situations, as well as their function in 
biological systems. Phospholipids are important molecules of the biological 
systems and their study has been growing, namely because the change of 
their structure induced by oxidative stress conditions that is being 
associated with several pathological conditions, namely Alzheimer, diabetes, 
age related diseases and also with  inflammatory response. 
Oxidative stress causes damage in important biological structures, like 
proteins, carbohydrates, lipids and nucleic acids. Among phospholipids, 
cardiolipin oxidation has received particularly special attention since it has 
been correlated with the cellular apoptosis. 
Oxidation reaction of phospholipids can generate numerous oxidation 
products. The nature of these species may depend on the local and degree 
of oxidation. It is also known that different oxidation species may have 
different biological roles in the living species [1]. 
In spite of the important role of cardiolipin oxidation, there is a limited 
knowledge about the modifications of this phospholipid that can be 
generated under oxidative stress conditions. Besides, the possibility of the 
formation of several oxidation products it turns out that it is important to 
define exactly which oxidation species are being created, since different 
cardiolipin oxidation products may exert different biological effects. 
Previous studies have lead to speculation that the accumulation of 
hydroperoxides form cardiolipin may be used has a biomarker of apoptosis 
in vivo. The ability of selective modulation of the cardiolipin oxidation may 
lead to targeted therapies and in last instance improve results after injury 
[2]. 
The identification and characterization of CL oxidations products by mass 
spectrometry and tandem mass spectrometry will be one important 
contribute to the fulfillment of the objective mentioned previously and will 
be executed in this work. 
Chapter I 
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1. Phospholipids 
The phospholipids are present in all organisms, from the arcobacter to 
plants and humans. These hydrophobic molecules are the building blocks of 
cell membranes, among other functions such as compartmentalization of 
the cytoplasm, storage of proteins involved in cell signaling, intercellular 
adhesion and cytoskeleton support, they also serve as a precursor for lipid’s 
biologically active mediators. There are two major groups of phospholipids: 
glycerophospholipids and sphingolipids.  
The glycerophospholipids are the most abundant phospholipids, they 
have a key role in energy storage and well as in cell structure, they are 
involved in cell signaling, cell proliferation and may serve as potential 
biomarkers for several diseases.  Glycerophospholipids usually consist of 
two fatty acids and a phosphate group attached to a glycerol molecule. The 
phosphate group can bind a polar molecule by an ester bond and  this part 
of the phospholipid molecule is called the headgroup of the phospholipid 
[3]. These combinations makes the glycerophospholipids, a group that 
besides abundant is very diverse, since it covers many combinations of 
lipids that vary according to their length, degree of unsaturation of acyl 
chains and the composition of the polar head group [4].  
The composition of the headgroup is primordial in dividing this 
phospholipid group to distinct classes, for example if it has a choline, then it 
belongs to the phosphatidylcholines (PC) class, on the other hand if it has a 
serine as a headgroup then it is a phosphatidylserine (PS), these classes 
along with the phosphatidylethanolamines (PE) and phosphatidylinositol 
(PI) are the main classes of polar phospholipids. It is believed that the 
temporal and spatial distribution of different classes of lipids has an 
important biological significance. Each phospholipid class has different 
combinations of fatty acids in positions sn-1 and sn-2 on the glycerol [5]. 
The Figure 1 represents the general structure of the glycerophospholipids.  
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Figure 1: General structure of the glycerophospholipids 
The cardiolipins are glycerophospholipids different from those previously 
presented. They may be considerate a distinct class of glycerophospholipids, 
since  cardiolipin  is a dimer that presents two phosphatidic acids linked 
together through an additional glycerol molecule and also four fatty acyl 
chains.  
The sphingolipids are amphipathic lipids usually found in cell 
membranes and contain sphingosine as a backbone (Figure 2). The addition 
of a fatty acid through an amid bond forms ceramide. Phosphorylation of 
sphingosine or ceramide results in sphingosine-1-phosphate (S1P) or 
ceramide-1-phosphate (C1P), respectively [6]. Sphingolipids are emerging 
as important mediators of cellular signaling, cell growth, and cell death, in 
addition to their structural contribution to membrane architecture [6-8], per 
example, sphingolipids are abundant components of the nuclear envelope in 
mammalian cells, where they modulate cell signaling to profoundly affect 
the function of the cell [9]. 
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Figure 2: The molecular structure of sphingosine, sphingosine-1-phosphate, ceramide and 
ceramide-1-phosphate. 
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2. Cardiolipin  
The cardiolipin (CL) was first isolated in 1942 by Mary Pangborn from 
bovine heart as ‘a substance essential for the reactivity of beef heart 
antigens in the serologic test for syphilis’ [10].  The CL, as described, 
presents an unusual structure and it can be found in all mammalian tissues, 
although it is more abundant in mammalian hearts It is found specifically in 
the mitochondrial inner membrane, where it has a central role in 
mitochondrial processes and energy metabolism. 
In this section I will approach all the features and functions related to the 
cardiolipin, their association with various proteins, relationship with 
cytochrome c and mitochondrial apoptosis and also its influence in several 
pathologies. 
2.1. Structure chemical and biosynthetic pathways  
CL can be defined as 1,3-bis(sn-3-phosphatidyl)-sn-glycerol. It is a 
dimeric phospholipid in which two phosphatidyl moieties are linked by a 
central glycerol group and also holds two more molecules of glycerol in its 
structure. The relationship between the three glycerol molecules creates a 
unique environment for each ester linkage [11](Figure 3). 
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Figure 3: Structure of cardiolipin. 
The fact that the headgroup alcohol is shared by two phosphate moieties 
is a feature with important implications regarding the overall physical 
properties of CL within the context of a lipid bilayer, namely in their mobility 
and conformational flexibility [12]. 
To understand the role of CL in mitochondria, it is necessary to know how 
it is formed and how it is integrated into mitochondrial membranes. 
Cardiolipin is synthesized from phosphatidic acid like all phospholipids [13]. 
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However the biosynthesis of the phosphatidic acid occurs in the 
endoplasmatic reticulum and in the outer mitochondrial membrane [14]. 
The other steps occur on the matrix side of the inner mitochondrial 
membrane. The mitochondrial inner membrane contains all the enzymes of 
the CL pathway, and the final step of this pathway is catalyzed by the 
cardiolipin synthase [14-15]. The Scheme 1 represented the synthesizing 
process of the CL from phosphatidic acid via a number of enzymatic steps 
[11]. 
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Scheme 1: Synthesis of cardiolipin. After synthesis of cytidinediphosphate-diacylglycerol 
(CDP-DAG) from phosphatidic acid, CL synthesis consist of the three steps, which all take 
place in the inner mitochondrial membrane. The first step is the formation of 
phosphatidylglycerophosphate (PGP) from CDP-diacylglycerol 3-phosphate by PGP synthase. 
In the second step, PGP is dephosphorylated by PGP phosphatase to produce 
phosphatidylglicerol (PG). In the final step, catalyzed by CL synthase, PG is combined with 
CDP-diacylglycerol to from CL [13]. 
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2.2. Cardiolipin acyl chain composition and subcellular 
distribution  
The composition of the CL is very diverse even within a single organism. 
The predominant composition in the mammalian tissue is the CL with 
linoleic acid (18:2) as fatty acid chains. In the hearth the tetralinoleoyl-CL is 
the more abundant species (the linoleic acid compromises 80-90% of the CL 
acyl chains). In the brain the most abundant species is the CL with long 
unsaturated fatty acid chains like arachidonic (20:4), docosatetraenoic 
(22:4) and docosahexaenoic (22:6). This instauration of the acyl chains of 
CL make it very susceptible to oxidative damage by reactive oxygen species 
(ROS) [13]. 
Some studies have shown that even though the predominant fatty acid 
species in CL of organisms may differ, there is a high degree of symmetry in 
the acyl chain distribution of CL in organisms and in tissues within the same 
organism [16]. The symmetric distribution of acyl chains is being considered 
to be important in promoting the structured organization of the 
mitochondrial membrane and to be of importance for the function of CL, as 
was reviewed elsewhere [17]. 
The CL if found almost exclusively in the inner mitochondrial membrane. 
In the bovine heart mitochondria the CL represents about 25% of all 
phospholipids. 
2.3. Cardiolipin and mitochondria 
CL is an integral part of the mitochondrial inner membrane where it is 
associated with many mitochondrial proteins. Therefore it has always been 
assumed to have an important role in mitochondrial function. CL maintains 
inner membrane fluidity and osmotic stability [11, 18] and it has a role in 
mitochondrial bioenergetics; CL electrostatically anchors cytochrome c to 
the inner mitochondrial membrane [19] and may therefore play an 
important regulatory role in cytochrome c release and apoptosis [20-22]. CL 
also plays an essential role in mitochondrial biogenesis [11], and the 
assembly of respiratory enzyme supercomplexes [23-24].  
Introduction 
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2.3.1. Interaction with mitochondrial proteins  
Cardiolipin has a unique ability to interact with a large number of 
mitochondrial proteins (Table 1), most of which reside in the inner 
membrane. The mitochondrial enzymes have been shown to require CL for 
optimal activity. 
Table 1: Cardiolipin-dependent mitochondrial proteins [11]. 
Protein  Mitochondrial compartment 
ADP-ATP carrier Inner membrane 
Phosphate carrier  
Pyruvate carrier  
Carnitine carrier  
Complex I (NADH: ubiquinone 
oxidoreductase)  
 
Complex II   
Complex III (ubiquinol: Cyt c 
oxidoreductase) 
 
Complex IV (Cytochrome c oxidase)  
Complex V (ATP synthase)  
Cytochrome P450SCC  
Cardiolipin synthase  
  
Cytochrome c Intermembrane space 
Creatine kinase  
CL interacts with all of the major players in oxidative phosphorylation, 
including respiratory complexes I, III, IV, and V. Restoration of enzymatic 
activity in phospholipid-depleted complex I and III has been shown to 
require the presence of cardiolipin [25]. The complex II has been associated 
with two acyl chains of one CL molecule from Escherichia coli [26]. Transfer 
of electrons between complex III and IV is dependent on cytochrome c 
which has been shown to interact loosely with CL [21]. Complex IV has 
been shown to require two associated CL molecules in order to maintain its 
full enzymatic function [27]. Complex V of the oxidative phosphorylation 
machinery also displays high binding affinity for CL, binding four molecules 
of CL per molecule of complex V [28]. 
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The ADP-ATP carrier is a good example of cardiolipin-protein interaction. 
The carrier belongs to many transport proteins for mitochondrial 
metabolites, but it has been shown to be optimal only in the presence of the 
tetralinoleoyl-CL. Other CL species, such as tetraoleoyl-CL and monolyso-
CL, and also other phospholipids were not effective in stimulating the ADP-
ATP carrier activity. The phosphate carrier [29] and the mitochondrial 
creatine kinase [30-31] require CL for their activity, however in contrast to 
cytochrome P-450 (it has been shown to be optimal after CL binding) [32], 
other phospholipids cannot substitute the CL [30]. Similarly the carnitine 
acylcarnitine translocase [33] and the pyruvate carrier [34] revealed to be 
best efficience in the presence of CL. The cardiolipin synthase also require 
CL for full activity, which is only achieved in combination with PE [35]. 
2.3.2. The interaction of CL with cytochrome c and its role in 
apoptosis 
Recently many studies focused the relationship of cytochrome c and 
cardiolipin in cellular apoptosis. Several  studies indicate that a structural 
destabilization of this protein, which can be caused by chemical 
modifications (i.e. oxidation, nitration) or by association with hydrophobic 
anions including anionic phospholipids [36-38], reveals a new function as a 
peroxidase [39].  Other studies show the mechanisms through which cyt c 
peroxidase activity propagates the oxidation of cardiolipin, and the essential 
role of this reaction in the execution of apoptosis [36, 40-41].  
The molecular interaction between CL and cytochrome c involves 
electrostatic interactions at the A-site of cyt c, whereas hydrophobic 
interactions and hydrogen bonding take place at its C-site [19].  To allow 
the release of cyt c to the cytosol it is necessary that the hydrophobic and 
electrostatic interactions between the CL and the cyt c are degraded [21], 
this hypothesis is supported by studies demonstrating that the peroxidation 
of CL virtually eradicate cytochrome c binding [42]. 
The Figure 4 shows the regulations of cytochrome c release from 
mitochondria. At the early stages of apoptosis, CL is redistributed to the 
outer monolayer of the mitochondrial inner membrane and to the outer 
mitochondrial membrane [40, 43-44]. Redistribution is liable to occur by 
interactions with proteins associated with apoptosis, such as Bid, tBid 
  
(truncated Bid, the active f
between the inner membrane and outer membrane 
will allow a sufficient amount of CL in intermembrane space so that it 
interacts with cyt c. The CL
potent in the presence
CL.  So cyt c release occurs after oligomerization and insertion of Bax and 
Bak promoted by tBid. The CL peroxidation mediated by RO
the dissociation of that association
activates the pro-caspase
Figure 4: Regulation of cytochrome 
membrane is permeabilized by tBid, which promotes the oligomerization and insertion of Bax 
and Bak. Cytochrome c release is initiated by the
binding to cardiolipin in the inner m
peroxidation (which is mediated by ROS). Once released into the cytosol, cytoc
triggers pro-caspase-9 activation via the apoptosome mechanism
2.3.3. CL and disease
Alterations of CL ha
conditions, such as neurodegenerative diseases, Barth syndrome or thyroid 
dysfunction, among others that will be described below.
contribute to the importance of lipidomic study, in order to o
knowledge and better understanding of the emergence of some diseases 
affecting children as well as elderly people.
orm of the protein) and Bax, in contact points 
[45]. This redistribution 
-cyt c complex formed can act with a peroxidase 
 of hydrogen peroxides originating hydroperoxides 
S will stimulate 
, releasing cyt c to the cytosol where it 
-9 via apoptossome mechanism [46]
c release from mitochondria. The mitochondrial outer 
 dissociation of the hemoprotein from its 
itochondrial membrane, which is stimulated by
 [46].  
 
ve been correlated with various pathological 
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Barth syndrome 
Barth syndrome (BHTS) is an X-linked recessive disorder, clinically 
characterized by the classical symptoms: cardiomyopathy, neutropenia, 
muscle weakness and loss of mitochondrial function [13]. BHTS is caused 
by mutations in the tafazzin (TAZ) gene [13, 47]. The TAZ gene product, 
while still unidentified, is believed to be involved in CL remodeling, as the 
TAZ mutation in BHTS is associated with marked alterations in CL 
metabolism. Patients with Barth’s Syndrome exhibit a loss of functional CL, 
in particular the tetralinoleoyl (18:2) form, in a variety of tissues. They also 
exhibit an increase in monolysocardiolipins [13, 48].  
Recent studies in yeast expressing the TAZ mutation exhibit a decrease 
in normal CL species containing oleoyl (C18:1) and palmitoleoyl (C16:1) 
acyl chains, an increase in monolysocardiolipin and destabilization of 
respiratory chain complexes. Incubation of fibroblasts from patients with 
BHTS with linoleic acid leads to an increase in tetralinoleoyl CL content, but 
effects of this treatment in patients await further investigation [13].  
Thyroid dysfunction  
Thyroid hormone is a regulator of mammalian mitochondrial biogenesis, 
respiratory function and lipid metabolism, and has been shown to directly 
modulate CL content by influencing the activity of CL biosynthesis enzymes. 
An increase in the mitochondrial concentration of CL upon thyroxin 
treatment was reported in rat heart and rat liver [11, 47], associated with 
an increase of the activity of multiple CL-dependent mitochondrial proteins 
and processes (see Table 1). A similar increase in enzyme activity was 
found for CL synthase and PG phosphate synthase. In contrast, 
hypothyroidism induced by chronic 6-n-propyl-uracil (PTU) treatment 
decreases levels of CL in heart mitochondria. The reduced level of CL was 
accompanied by lower activities of pyruvate carrier, the carnitine carrier and 
cytochrome oxidase [11]. 
The specific role of CL loss in the PTU-induced decreased in complex IV 
activity was demonstrated in a study by Paradies et al. [49], where enzyme 
activity was completely restored by reconstituting hypothyroid cardiac 
mitochondria with exogenous CL liposomes. 
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Diabetes  
Diabetes is a metabolic disease characterized by insulin deficiency (type 
1) or insensitivity (type 2), resulting in chronic hyperglycemia and a variety 
of systemic complications, including neuropathy and cardiomyopathy. 
Alterations in CL content have been hypothesized to precede the causes of 
cardiomyopathy, which could be caused by a mitochondrial dysfunction 
[50]. 
The influence of the CL changes in the development or progression of 
diabetic cardiomyophaty is still unclear. There are conflicting results, in 
streptozotocin-treated rats (a model of type 1 diabetes), mitochondrial CL 
content has been reported to decrease in the rat brain, increase in the rat 
liver, or remain unaltered in the rat heart [47]. 
Tangier disease 
Tangier disease is characterized by very low plasma levels of high-density 
lipoprotein cholesterol, accumulation of cholesteryl esters in tissues and an 
increased risk for developing cardiovascular disease [50-51]. Tangier 
disease is mainly caused by abnormal enhanced production of CL. Studies 
show that there are three to fivefold increase in the levels of CL, monolyso-
CL and dilyso-CL in cultured Tangier disease fibroblasts [50, 52]. Because 
increased CL levels would enhance cholesterol oxidation, and then the 
formation of oxysterols would consequently increase cholesterol efflux. This 
process could function as an escape mechanism to remove excess 
cholesterol from the cell [50, 52]. 
Aging 
An age-related loss of CL was shown in mitochondria from rat heart, rat 
liver, rat brain mitochondria and in epidermal cells from humans [11]. 
Oxidative injury of mitochondria is widely believed to play an important 
role in mitochondrial decay and dysfunction seen in aging [47]. CL comprise 
in it constitution mainly polyunsaturated acyl chains which are more 
susceptible to peroxidative damage; age related accumulation of free 
radicals is responsible for the decline CL [47].  
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Low levels of CL in aged mitochondria were associated with decreased 
activities of mitochondrial enzymes such as, a phosphate transporter, 
pyruvate carrier, carnitine and cytochrome oxidase [11]. 
Neurodegenerative disease 
Alterations in CL have been associated with Alzheimer’s disease and 
Parkison [47]. As reported previously, CL peroxidation is involved in cell 
apoptosis and mitochondrial dysfunction and is believed to be important 
contributing factors leading to neuronal loss. 
Decreased in CL have been reported to occur  in the brain with aging, 
and probably  associated with an increase of lipid peroxidation in rat brain 
mitochondria exposed to free radical stress. A study by Ellis et al. [53] 
provides intriguing evidence for a potential role of CL alterations in 
Parkinson’s disease. 
2.4. Cardiolipin oxidation  
Cardiolipin is particularly susceptible to oxidation by reactive oxygen 
species (ROS) due to the presence of the double bonds in acyl chains, such 
as linoleic acid or docosahexanoic acid and also due to it association with 
the electron transport chain (ECT), a major site of ROS production. CL 
peroxidation has been shown to play a critical role in several 
physiopathological situations as well as in cell death, as mentioned before. 
In order to understand the modification that occur in CL during oxidation 
some work was done by some research groups in recent years. Oxidation of 
the CL was promoted by different ways. Kagan and collaborators verified 
that CL is oxidized by γ–irradiation induced intestinal injury [54]. The 
irradiation induces radiolysis of water and generation of reactive radicals, 
which initiated oxidative damage. They hypothesized that CL oxidation may 
be an important step in the mitochondrial stage of the γ–irradiation-induced 
apoptotic program in the intestine in vivo and, if so, represents an 
important target for the discovery and development of radioprotectors and 
radiosensitizers. They also speculated that oxidized molecular species of CL 
and PS can be used as early biomarkers of γ–irradiation-induced intestinal 
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apoptosis in vivo. They identified using electrospray mass spectrometry 
(ESI-MS) hydroperoxides derivatives as result of this oxidation process.    
Shadyro and co-workers show oxidative modification of cardiolipin 
induced by γ–irradiation in a model membrane [55-56], using matrix-
assisted laser desorption ionization time-of-flight (MALDI-TOF) mass 
spectrometry. They showed the formation of phosphatidic acid in the course 
of radiolysis of cardiolipin. 
The CL oxidation by cyt c/H2O2 has been recently studied extensively by 
Tyurin et al.  [57-58] as well as, Yourkova et al. [59]. They incubate at 
37°C the CL liposomes with cytc/H2O2 and analyzed their results by ESI-MS 
and MALDI-MS. Hydroperoxy- and hydroxyl- derivatives of CL, were 
identified as primary peroxidation products whose subsequent oxidative 
degradation lead to the formation of a large variety of the other derivatives.  
The Yurkova and co-workers used a system under the same conditions 
where hydrogen peroxide favors a release of the heme iron cyt c obtaining 
phosphatidic acid (PA) and phosphatidylhydroxyacetone (PHA) via an OH-
induced fragmentation taking place in the polar moiety of CL. 
The Yurkova et al. have been oxidizing the CL in the different ways; apart 
from oxidation by cyt c / H2O2 and γ–irradiation they also tested other 
methods in order to obtain the PA and PHA in CL liposomes. They induced 
oxidation by using the hydroxyl radical generated by ascorbate/ Fe2+/H2O2 
as oxidizing system on CL resulting in the formation of PA [60]. Oxidation 
by Cu2+/H2O2/ascorbate caused the formation of PA and PHA in CL 
liposomes [61].  
The oxidation by hydroxyl radical, usually generated by the Fenton 
reaction uses iron ions (Fe2+) as reaction catalysts, for the production of 
ROS, from hydrogen peroxide (H2O2). 
Fe2+ + H2O2 → Fe
3+ + .OH + OH- 
The hydroxyl radical is the most reactive oxygen species generated in living 
systems, being responsible for the oxidation of biomolecules, including 
lipids. 
The lipid peroxidation induced by the hydroxyl radical is initiated by the 
abstraction of one hydrogen atom from a reactive methyl group (C-H), 
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producing alkyl radicals (R.). This alteration will promote the reorganization 
of the adjacent double bonds producing other alkyl radicals. In the presence 
of oxygen, the alkyl radicals will react to from peroxyl radicals (ROO.) that 
in turn, by acquiring one hydrogen atom, produce one lipid hydroperoxide 
(ROOH), which will promote various oxidation reactions. The resulting 
peroxide may be cleaved yielding alcoxil (RO.) or epoxiperoxil (OROO.) 
radicals. These species can abstract hydrogen atoms from lipids and 
propagate the lipid peroxidation reaction. 
During oxidation, oxygen atoms are inserted with formation of oxidation 
products with higher molecular weight. These products are named long-
chain oxidation products. But the alkoxyl radical formed during the oxidative 
reaction may undergo posterior beta cleavage of the fatty acyl chain with 
formation of oxidation products with shortened fatty acyl chain, and with 
aldehydic or carboxylic terminal function. These products have lower 
molecular weight and are called short-chain phospholipid products (Scheme 
2). The CL possesses for fatty acid chains that maybe unsaturated, thus 
being susceptible to oxidation. The tetralinoleoyl-cardiolipin, the most 
abundant cardiolipin in mammalians, possesses four linoleoyl fatty acyl 
chains. This fatty acyl chain has two double bonds in the carbon 9 and 12. 
The bis-allylic hydrogen (found in between the two double bonds) is very 
unstable; in the presence of oxidant agents this hydrogen is abstracted 
leading to the dislocation of the double bond for the 10 or 11 carbon, 
leaving a free radical in the carbon 9 or 13 respectively [62-64]. 
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Scheme 2: Generation of the long chain and short chain oxidation products by radical 
oxidation. 
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3. Experimental approaches in Lipidomics research 
The typical study of lipids from biological samples (lipidomic) usually 
involve several steps, beginning with  the extraction of lipids from tissues or 
cells, additional  analyses of the lipid profile through mass spectrometry 
with or without chromatographic separation (Figure 5). This methodology is 
also applied in the analysis of lipid peroxidation products that are generated 
in in vivo conditions, named as oxidative lipidomic. 
 
Figure 5: Lipidomics - techniques employed in the analyses of lipids. 
Analysis of CL oxidation products has also been carried out using 
separation techniques and mass spectrometry (MS) and tandem mass 
spectrometry (MS/MS) [58]. The separation of lipids from biological samples 
can be conducted using HPLC that has the advantage of being coupled to 
MS, (LC-MS) or by TLC. TLC is nowadays an important technique used for 
the separation of different classes of phospholipids in biological samples. 
3.1. Separation methods  
3.1.1. Thin layer chromatography 
Thin layer chromatography (TLC) is a method of separating compounds in 
the mixture. TLC can also be used for quantify, identify and purify 
components present, in a mixture. Like all chromatographic methods, TLC 
takes advantage of the different affinity of analyte with the mobile and 
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stationary phases to achieve separation of complex mixtures, TLC is then a 
solid-liquid adsorption technique in which the solvent molecules compete 
with the molecules of the solute (sample) for binding sites  on the 
stationary phase.  
Silica gel, the most commonly used stationary phase, has the empirical 
formula SiO2. However, at the surface of the silica gel particles, the 
dangling oxygen atoms are bound to protons. The presence of these 
hydroxyl groups renders the surface of silica gel highly polar. Thus, polar 
functionality in the organic analyte interacts strongly with the surface of the 
gel particle and nonpolar functionality interacts only weakly. Analyte 
molecules can bind to the silica gel in two ways: through hydrogen bonds 
and through dipole-dipole interactions.  
For silica gel chromatography, the mobile phase is an organic solvent or 
mixture of organic solvents. As the mobile phase moves along the surface 
of the silica gel it transports the analyte particles of the stationary phase. 
However, the analyte molecules are only free to move with the solvent if 
they are not bound to the surface of the silica gel. Thus, the fraction of time 
that the analyte is bound to the surface of the silica gel relative to the time 
it spends in solution determines the retention factor of the analyte. The 
ability of an analyte to bind to the surface of the silica gel in the presence of 
a particular solvent or mixture of solvents can be viewed as a the sum of 
two competitive interactions. First, polar groups in the solvent can compete 
with the analyte for binding sites on the surface of the silica gel. Therefore, 
if a highly polar solvent is used, it will interact strongly with the surface of 
the silica gel and will leave few sites on the stationary phase free to bind 
with the analyte. The analyte will, therefore, move quickly past the 
stationary phase. Similarly, polar groups in the solvent can interact strongly 
with polar functionality of the analyte and prevent interaction of the analyte 
with the surface of the silica gel. This effect also leads to rapid movement of 
the analyte past the stationary phase. 
The category in which silica is found as the stationary phase is designed 
by normal phase TLC in which the more non-polar compounds have more 
affinity with the mobile phase and so elute in front of the more polar 
compounds which have higher affinity with the stationary phase. There’s 
another category, TLC of reverse phase, in which the stationary phase is 
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constituted by linked carbon chains usually with 18 carbons and the mobile 
phase is constituted by more polar solvents, and therefore the order of 
solute elution is inverse to the one verified with normal phase TLC. 
This technique is used, in lipid analyses for the separation of different 
lipid classes from total lipid extracts obtained from animal and plant tissues. 
It is relatively easy and fast to separate, per example, the nonpolar lipids 
(triglycerides, free fatty acids, cholesterol and diacylglycerols) from more 
complex lipids like phospholipids, and also achieve separation even within 
the phospholipids. When using adequate mixture of solvents it is possible to 
separate and quantify the different lipid classes [65]. 
3.1.2. High-Performance Liquid Chromatography 
The liquid chromatography (LC) is a separation technique based on the 
distribution of the components of a mixture, which occur in the liquid phase. 
A sample is separated into its constituent components (or analytes) by 
distributing between the mobile phase (a flowing liquid) and a stationary 
phase (sorbents packed inside a column) [66].  
The principles of HPLC are similar to TLC. However this is an automated 
technique and is described and measured in terms of four major concepts: 
capacity, efficiency, selectivity, and resolution. The capacity and selectivity 
of the column are variables and depend largely on the column 
manufacturer, whereas efficiency and resolution can be controlled, to some 
extent, by the chromatographer. To obtain the best possible separation, the 
efficiency of the chromatographic system must be optimized in order to 
minimize band broadening. The column must have the capability to retain 
the solutes, and it should have the appropriate selectivity to resolve the 
analytes of interest [67]. 
A typical HPLC system consists of a pump, an injector, a column, a 
detector, and a data-handling device (Figure 6). 
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Figure 6: The main components of the HPLC 
(http://www.lcresources.com/resources/getstart/) 
This technique has been used in the analysis of lipids, either in normal 
phase and reverse phase, either alone or in association with mass 
spectrometry, in a lipidomic approach. Nowadays the HPLC is usually 
coupled with mass spectrometry (LC-MS); this technique has been widely 
used in the phospholipid study and also in the analysis of phospholipid 
oxidation products [68-69]. 
3.2. Mass spectrometry  
The mass spectrometry was the main method used for the analysis and 
monitoring of the CL oxidation. This technique has been widely used in the 
study of oxidized phospholipids [5, 57-59, 61, 68, 70], since one of its main 
advantages is its sensibility. 
The components of a mass spectrometry instruments are (Figure 7): 
- A system to allow the introduction of the sample in the source. This 
system can be conducted through direct injection or using a coupling of GC-
MS, LC-MS; 
- Ionization source, where a beam of ions from the sample is produced; 
- Analyzers, that allow the separation of the ions in accord with their ratio of 
mass/charge (m/z); 
- Detectors where the ions are collected. These are connected to a 
computer that provides mass spectra recording according to the relative 
abundance in function of the m/z of each ion. 
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Figure 7: Components of a mass spectrometer. 
In the analysis of the phospholipids and phospholipid oxidation products 
(including CL oxidation products) two ionization methods are used: 
electrospray (ESI) and matrix assisted laser desorption ionization (MALDI).  
Several analyzers are available in the mass spectrometers, including 
quadrupole, ion trap, TOF, among others. They can be alone in a mass 
spectrometer, or combined such as in the Q-TOF mass spectrometers, triple 
quadrupole instruments (having two quadrupole analyzers), Q-Trap 
(combining one quadruple and one ion trap analyzers). In this work we used 
an ESI-ion trap coupled to LC.  
3.2.1. Ionization source 
Electrospray (ESI) 
In ESI a solution containing the analyte of interest is continuously infused 
through a metal needle using a syringe pump.  A high voltage is applied to 
the needle. This high voltage will charge the molecules of the solvent, in 
which the sample is mixed, as well as the sample molecules, producing ions 
such as [M+H]+ or [M-H]- depending on the chemical properties of the 
molecules. 
Once they are charged, with the same charge, the molecules will repel 
one another. This repulsion will force the liquid to exit trough the tip. When 
the liquid exits it first forms a cone known as Taylor cone; after that, the 
droplets burst forming the final spray. 
After release the droplets, they undergo further division and with the 
assistance of nitrogen gas the solvent will gradually evaporate. When the 
Sample
Source Analyzer Detectors
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ions become close enough together their electric charges will make them 
repel each other, because of the Coloumb force. This will force the droplets 
to divide into smaller droplets until each droplet corresponds to a single 
charged molecule and the solvent is completely evaporated (Figure 8). This 
ionization has the advantage that the molecules are not broken apart, 
instead they remain intact; this is why this ionization is called soft 
ionization.  
 
Figure 8: Schematic representation of ionization by ESI (http://www.magnet.fsu.edu/). 
 The ESI has been widely used in the analysis of biomolecules; its great 
success in the analysis of proteins is due to its ability of producing multiple 
charges allowing the analysis of compounds with a higher molecular weight. 
Electrospray ionization is widely used in lipidomics, and since lipids have a 
low molecular weight when compared to proteins, they ionize under ESI 
conditions as single charged ions which facilitate their analysis by ESI-MS.  
MALDI 
In MALDI, ions are desorbed from the solid phase. A sample is first 
dissolved in a suitable solvent and mixed with an excessive amount of an 
appropriate matrix. The most common matrix in lipid analysis is 2,5-
dihydroxybenzoic acid (DHB).Than the matrix and analyte mixture are 
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irradiated with a laser beam. Light energy is absorbed by the crystals and 
dissipated, with the result that protonated or desprotonated sample 
molecules and the matrix pass to the gas phase [71] (Figure 9). 
 
Figure 9: Schematic representation of the ionization of the sample in MALDI 
(http://www.magnet.fsu.edu/). 
This ionization method results predominantly in the generation of mono-
charged molecules. Some phospholipids are easily protonated 
(phosphatidylcholine and phosphatidylethanolamines) and, consequently 
these are preferably analyzed in the positive ion mode, while others, such 
cardiolipin and phosphatidylinositol, are more easily desprotonated and 
analyzed in negative ion mode. 
The produced ions are usually analyzed by TOF analyzers, and more 
recently analyzed by TOF-TOF geometry that allowed tandem mass 
experiments, which provided additional structural information, with high 
resolution and accuracy. 
3.2.2. Analyzers  
Linear Ion trap 
The linear ion trap is an analyzer based on the four-rod quadrupole 
ending in lenses that repel the ions inside the rods. The ions are confined to 
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a radial dimension by a quadrupole field and to an axial dimension by 
means of an electric field in the trap extremity. 
This analyzer can be combined with other mass analyzers and used to 
isolate ions of selected mass to charge ratios, to perform tandem mass 
spectrometry experiments, and to study ion molecule chemistry [72].  
Experiments thus far demonstrate the great ion capacity or space charge 
limits of this device along with a high trapping efficiency of injected ions and 
low mass discrimination [73]. 
Quadrupole 
The quadrupole is composed by for parallel rolls to which it is applied a 
direct current and an alternate current that affects the path of the ions. 
Only the ion with a certain m/z value will manage to reach the detector. The 
rest will collide with rods and will be ejected. 
The major advantages of quadrupole analyzers are the low cost, 
relatively small size, robustness, and ease of maintenance. A quadrupole 
possesses, however, limited capability in terms of mass range (usually 
<4000 Da), resolving power, and the ability to perform MS/MS analysis. The 
final disadvantage can be overcome by attaching a quadrupole to other 
analyzers such as additional quadrupoles (triple quadrupole instrument) or 
a quadrupole linked to a TOF (Q-TOF) [74]. 
Time of flight  
The TOF analyzer uses the time that the generated and accelerated ions 
take to reach the detector. These ions are accelerated by an electric field 
pulse. All the ions are accelerated with the same energy; their velocities are 
inversely proportional to the square root of their mass, so the lighter ions 
gain higher speeds and reach the detector before the ions with higher mass 
and low velocities. 
3.2.3. Tandem Mass Spectrometry (MS/MS)  
The Tandem mass spectrometry is based in the isolation of a specific m/z 
value (precursor ion) that may be submitted to dissociation and subsequent 
production of ion fragments. To achieve this goal, several analyzers are 
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coupled in series in a way that the isolation is performed by the first 
analyzer, followed by fragmentation in the collision cell; the fragmented 
ions are separated based on their m/z value by the last analyzer. However 
some instruments (linear ion trap and FT-ICR) with just one analyzer are 
able to perform multiple MS (MSn), becoming efficient instruments in the 
structural identification of several molecules including the phospholipids. 
[75-77]. 
This technology is necessary since the soft ionization methods used 
nowadays produce mass spectra where fragmentation is absent, as so, they 
do not provide much information about the molecular structure. For that 
purpose we need to proceed to the fragmentation of the desired ion 
inducing the dissociation. 
 Using this technology we can draw several conclusions about the 
structure of the analyzed molecules and the spectra obtained give us not 
only the most frequent molecular fragmentation but also as the most 
favorable.
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4. Mass spectrometry in the analysis of cardiolipin 
 Mass spectrometry has been used for the structural characterization of 
cardiolipin. Hsu and Turk described the cardiolipin fragmentation by 
electrospray tandem mass spectrometry using either a quadrupole or 
multiple-stage quadrupole Ion-trap, in negative mode. Cardiolipin ionizes 
under ESI conditions  as double- and mono-charged ions ([M-2H]2- and [M-
H]-) [76] and also as sodium adducts ([M-2H+Na]-) [78]. The analysis of 
sodium adducts was also performed in positive mode ([M+Na]+ or [M-
2H+3Na]+) [75]. This group proposed specific fragmentation pathways of 
the [M-H]- ion of CL, as resumed in Scheme 3. 
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Scheme 3: Typical Fragmentation of CL as [M-H]- ion. 
 
Studies using mass spectrometry to analyze CL included one published by, 
Beckedorf and co-works [79] that use in positive and negative mode 
obtained by nanoESI-QTOF-CID-MS, and MS/MS for detailed structural 
characterization of the D-glucopyranosylcardiolipin. Valianpour et al. [80] 
also used electrospray ionization mass spectrometry for CLs analysis in in 
vivo samples from  patients Barth syndrome. 
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Cardiolipin oxidation was studied, as reported before, using ESI-MS and 
MS/MS by Kagan group. They analyzed oxidation products of CL in several 
biological samples in negative mode [M-H]-and [M-2H]2- [2, 54, 57-58, 81]. 
MS/MS of the [M-H]- ions, yielded the oxidized R’2COO
-, confirming the 
occurrence of the oxidative modifications in sn-2 fatty acyl chain. MS3 was 
used for the analysis of R2COO
- of the CL-OOH and CL-OH. The authors 
suggested, for the CL-OOH, the formation of the 9-s-OOH-C18:2 and 13-s-
OOH-C18:2; and for CL-OH, the formation 9-s-OH-C18:2 and 13-s-OH-C18:2 in 
a model system during cyt c driven CL peroxidation in vitro [54].  
MALDI-MS have been used by Shadyro and collaborates [55-56, 59-61] for 
analysis of cardiolipin oxidation and identify the phosphatidic acid and 
phosphatidylhydroxyacetone as oxidation products products of CL generated 
from cleavage on central glycerol molecule. 
However, there is still need of a deeper knowledge about oxidation product 
that can be generated during CL induces from different conditions. 
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5. Aims 
As mentioned previously, the oxidation of CL may generate numerous 
oxidation products and the nature of these species may depend of the local 
and degree of instauration, so it is important to define exactly which 
oxidative species are being created, since different oxidation products may 
potentially exert distinct biologic effects. 
Despite the importance of CL oxidation there are few studies in this topic; 
only the products that are formed initially were identified and their 
characterization lacked detail. 
So the aim of this work is to identify and characterize with great detail, 
using mass spectrometry coupled with separation techniques, all the 
oxidation products resulting from the oxidation of cardiolipin: long-chain 
and short-chain. 
Mass spectrometry is a very useful technique in the identification and 
characterization of the products formed due to oxidative stress. It is used in 
study of cardiolipin oxidation, as mentioned before, as well as other 
phospholipids oxidation like the PC and the PE [62-63, 68, 70]. In this work 
the oxidation products of cardiolipin will be studied in detail using ESI-MS, 
ESI-MS/MS and LC-MS/MS. 
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Abstract 
Cardiolipin (CL) is found almost exclusively in the inner mitochondrial 
membrane. Alteration of CL, namely by oxidative modifications, has been 
related with various pathological conditions, and with cell apoptosis. Their 
location, in the mitochondria, makes them even more likely to be oxidized, 
since that there is a considerable production of ROS in the inner 
mitochondrial membrane. In spite of the importance of CL oxidation and its 
biological consequence, there is a limited knowledge of the oxidation 
products of CL.  
In this study, mass spectrometry coupled with liquid chromatography 
(LC-MS) was used to identify the specific oxidative modifications of tetra-
linoleoyl CL induced by the OH• generated under Fenton reaction conditions 
(H2O2 and Fe
2+). Short-chain products (with fatty acyl shortened) formed 
during CL oxidation were identified for the first time and were further 
characterized by LC-ESI-MS/MS. The short-chain products identified 
resulted from β-cleavage of alkoxyl radicals at C9 and C13. These products 
were identified as [M-2H]2- at m/z 691 and 719, with C13 and at m/z 685, 
693 and 701, with C9 shortened fatty acyl chains. Detailed analysis of the 
fragmentation pathways of these precursor ions allowed to identify the 
MS/MS product ions which allow the unequivocal assignment of the oxidized 
cardiolipin species, very valuable for their detection in biological samples. 
Some of these products, namely, the CL short chain product at m/z 685 and 
693 were detected in the mitochondria of kidneys obtained from rats 
treated with gentamicin. Gentamicin is an aminoglycoside antibiotic that 
induces nephrotoxicity and that has been associated with mitochondrial 
dysfunction and lipid peroxidation. 
 
Keywords (6): cardiolipin, oxidation, hydroxyl radical, mass 
spectrometry, LC-MS, mitochondria    
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Introduction 
Cardiolipin (CL) is a phospholipid found mainly in the inner mitochondrial 
membrane. CL is associated with different proteins of the complexes of the 
respiratory chain, which are involved in the transduction of electrons and 
the production of ATP in the mitochondrial inner membrane, conferring to 
CL a central role in mitochondrial processes and in energetic metabolism [1-
3]. Alteration of CL structure, namely by oxidative modifications or change 
in the fatty acyl profile, and change in mitochondria CL content have been 
correlated with various pathological conditions, particularly in 
neurodegenerative diseases , such as Barth syndrome, Parkinson and 
Alzheimer diseases and in cell apoptosis [3-4]. 
CL has a more complex structure, when compared with the other 
phospholipids, bearing four chains of fatty acids that can diversify in length 
and degree of unsaturation. The structural characteristics of CL and its 
oxidize species is postulated to be important in different biological functions 
[5-6]. Like the other phospholipids, and also due to the presence of the 
double bonds in fatty acyl chains, CL is susceptible to oxidative damage by 
reactive oxygen species (ROS) [1, 7-8]. Their location, in the mitochondria, 
makes them even more likely to be oxidized, since that there is a 
considerable production of ROS in the inner mitochondrial membrane [1, 4, 
7]. ROS, and mainly OH•, are involved in oxidative stress modification of 
distinct biomolecules, namely lipids, proteins and nucleic acids, leading to 
changes in their structure and in consequence, loss or modification of their 
function. In particular, oxidation of CL is thought to be a key intermediate in 
cells apoptosis. Oxidation of CL is closely related with cellular apoptotic 
mechanisms which have being associated with nephrotoxicity of several 
drugs, such as aminoglycosides and immunosupressors [9-11]. In spite of 
the importance of CL oxidation and its biological consequence, there is a 
limited knowledge of the oxidation products of CL.  
Notwithstanding the importance of the consequences of CL oxidation, and 
the fact that in the last few years there is an increasing interest in the study 
of CL, there is a limited knowledge of the oxidation products of CL. During 
ROS oxidation, numerous oxidation products may be formed [6]. It is very 
important to identify each specific oxidation product in order to understand 
their specific biological significance and effects [6]. Mass spectrometry has 
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been used for the identification of specific structures of phospholipids 
oxidation products generated during distinct oxidative processes [12]. ESI-
MS and MS/MS in negative mode have been used, by Kagan et al, to 
identify the CL oxidation induced by different conditions, namely in the 
presence of cytochrome c/H2O2, by γ – irradiation induced intestinal injury 
[13], after traumatic brain injury [14], during staurosporine-induced 
apoptosis [15] and by pro-inflamatory stimuli, using LPS [16]. They noticed 
oxidation of CL by the accumulation of different combinations of hydroxy 
and hydroperoxy group in CL, although peroxyl derivative seems to be 
formed preferentially. In a more recent study, they used tandem mass 
spectrometry to identify and confirm the proposed conjugations and their 
location along the fatty acyl chain of the CL molecules [16].  
Phosphatidic acid and diacylphosphatidyl-hydroxyacetone were also 
identified as oxidation products of CL by Yurkova et al. and Shadyro and co-
workers, in an oxidative process that conduct to cleavage of the CL 
molecule [13, 17-19]. In these works γ-radiation, Cu2+/H2O2/ascorbate, or 
cytochrome c mediate oxidation were used to induce modifications on CL, 
and the oxidation products were identified by MALDI-MS in positive mode. 
However, MS/MS studies were used to confirm and characterize these 
oxidation products. 
 
In order to bring new knowledge on the oxidative modifications 
undergone by CL in presence of free-radicals, mass spectrometry coupled 
with liquid chromatography (LC-MS) was used to identify the specific 
oxidative modifications of tetra-linoleoyl CL induced by the OH generated 
under Fenton reaction conditions (H2O2 and Fe
2+). Tetra-linoleoyl CL has 
been chosen because it is an abundant form in almost mammalian tissues. 
Detailed discussion of the fragmentation products will be done in order to 
pinpoint the specific ions that may allow their unequivocal assignment, 
which may be useful for their detection in biological samples. Experimental 
studies on nephrotoxicity of aminoglycosides have shown that cell apoptosis 
is induced [9-11]. Thus, the nephrotoxicity of aminoglycosides 
administration could be connected to oxidative modifications on cardiolipin. 
To evaluate the possible accumulation of CL oxidation products under this 
apoptotic conditions, comparison of CL profile from kidney mitochondria of 
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rats treated with gentamicin and rats without treatment was done using 
tandem mass spectrometry, using the data provided by the in vitro 
oxidation of tetra-linoleoyl CL. 
 
Experimental 
 
Materials  
Tetra-linoleoyl CL was purchased from Sigma and was used without further 
purification. Ferrous chloride and hydrogen peroxide (30%, w/v) were used 
for oxidation reactions and were obtained from Merck (Darmstadt, 
Germany). Triethylamine (Acros organics), chloroform (Analitycal reagent 
grade) methanol (HPLC grade), ethanol absolute (Panreac). TLC silica gel 60 
with concentrating zone (2.5×20cm) was purchased from Merck (Darmstad, 
Germany).  
 
Animals 
Adult male Wistar rats were maintained at a temperature 23 ± 2°C, 50-
55% humidity, and a lighting cycle of 12 hours light and 12 hours dark. 
Commercial rat pellets and water were available ad libitum. Twelve adult 
male Wistar rats weighting 200-250 g were randomly divided in two groups 
(6 rats) as follows: (i) control group: treated subcutaneously with isotonic 
saline solution for 8 days; (ii) Gentamicin group (GEN): treated 
subcutaneously with gentamicin (60 mg/kg) for 8 days. All administrations 
were made at 9:00 a.m. Rats were anesthetized by inhalation of isofluoran 
(Abbott Laboratories, Sweden) immediately before being sacrificed. The 
experiments were performed according to international guidelines 
concerning the conduct of animal experimentation.  
 
Isolation of rat kidney mitochondria  
 Mitochondria were extracted from a homogenate of rat kidney by 
differential centrifugation according to Cain and Skilleter (1987) [20]. 
Capsule was removed and the remaining organ was cut into pieces and then 
minced and homogenized with a Potter-Elvehjem in a medium containing 
0.25 M sucrose, 20 mM HEPES, 1 mM ethylene-diaminetetraacetic (EDTA), 
0.2 % (w/v) defatted bovine serum albumin, pH 7.4. Mitochondria isolation 
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was performed at 4 °C without delay using differential centrifugation. The 
homogenate was centrifuged at 800 g for 10 min, and the resulting 
supernatant was centrifuged at 10.000 g for 10 min. The mitochondrial 
pellet was washed twice and re-suspended in a medium containing sucrose 
0.25 M, 20 mM HEPES, pH 7.4 and suspended at 30 mg protein mL-1. 
Protein concentration was determined by the biuret method using bovine 
serum albumin as a standard [21]. 
 
Lipid extraction and TLC analysis  
The Bligh and Dyer [22] procedure was used to extract total lipids from 
each mitochondrial preparation. The lipid extracts were flushed with 
nitrogen, capped, and stored at -20ºC for ESI/MS analysis. Lipid extracts 
were separated and analyzed by thin-layer chromatography (TLC) plates 
(silica gel 60 with concentrating zone 2.5×20cm, Merck, Darmstadt, 
Germany). Prior to separation, plates were treated with boric acid 2.3% in 
ethanol. The plates were developed in solvent mixture 
chloroform/methanol/water/triethylamine (30:35:7:35, v/v/v/v). Lipids 
spots on TLC plates were observed by exposure to iodine vapors and 
indentified by comparison with authentic phospholipid standards. Spots with 
cardiolipin were scraped from the plates and the CL were extracted using 
chloroform/methanol (1:1, v/v) 
 
Oxidation of cardiolipin by Fenton reaction 
Ammonium bicarbonate buffer 5mM (pH 7.4) was added to 0.5 mg of CL, 
and then the solution was taken to the vortex and the sonicator for the 
formation of vesicles. The oxidation was performed by adding to the 
solution 40µM of FeCl2 and 50mM of H2O2 to a total volume of 250 µL. The 
mixture was incubated at 37°C in the dark for several hours. Controls were 
performed by replacing hydrogen peroxide with water. 
 
LC-ESI-MS conditions 
The RPLC-MS and RPLC-MSn studies were conducted on a Waters Alliance 
(Milford, USA) Model 2690 equipped with a pre-column split (Accurate, LC 
Packings, USA) and an ACE 3 C18-AR column (150×1.0mm i.d.) kept at 
room temperature (22°C). The reaction mixture was diluted 50 fold before 
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injection and a volume of 10 µL was introduced into the column, using a 
flow rate of 25µLmin-1. The phospholipid oxidation products were separated 
using water-methanol (90:10, v/v, eluent A) and methanol (100%, eluent 
B) programmed as follows: a linear increase from 90%B to 100% B in 15 
minutes and held isocratically for 20 min. The mobile phase was brought 
back to the initial elution conditions in 10 min and allowed to equilibrate for 
15 min until the next injection. 
The LXQ linear ion trap mass spectrometer (ThermoFinnigan, San Jose, CA) 
was operated in negative mode. Typical ESI conditions were as follows: 
electrospray voltage was 4.7 kV; capillary temperature was 275°C and the 
sheath gas flow was 25 units. An isolation width of 0.5 Da was used with a 
30 ms activation time for MS/MS experiments. Full scan MS spectra and 
MS/MS spectra were acquired with a 50 ms and 200ms maximum ionization 
time, respectively. Normalized collision energyTM (CE) was varied between 
15 and 20 (arbitrary units) for MS/MS. Data acquisition was carried out on 
an Xcalibur data system (V2.0). 
 
Results and Discussion 
Oxidation of CL was induced by the hydroxyl radical generated under 
Fenton reaction and the oxidations products were monitored by ESI-MS in 
negative mode. Cardiolipin ionizes, under ESI-MS conditions, as mono-
charged ions [M-H]- and di-charged ions [M-2H]2-. Comparing the ESI mass 
spectrum obtained for the cardiolipin after oxidative reaction with the ESI-
MS spectrum of cardiolipin in non-oxidative conditions (Figure 1), new ions 
were observed as [M-2H]2- species, at m/z values lower than the [M-2H]2- 
ions of native CL and attributed to oxidation products. The same oxidized 
species were observed as monocharged ions but with much lower relative 
abundance, when compared with the double charged ions. These oxidation 
products [Figure 1(b)] are observed at m/z 685, 691, 693, 701 and 719 and 
are proposed to be formed by carbon chain cleavage during fatty acyl 
oxidation. These species are formed due to an initial abstraction of 
hydrogen atom from one or more fatty acyl chains, with further cleavage of 
fatty acyl backbone and formation of carbonylic or carboxylic terminal 
functions, as reported for lipid peroxidation reaction and reviewed 
elsewhere [23-25]. In fact, the formation of an additional terminal 
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carboxylic function may justify the most favorable formation of double 
charged ions, since it corresponds to the removal of one more labile 
hydrogen that facilitates the formation of [M-2H]2- ion species. Based on the 
molecular weight of these short chain oxidation products, it is proposed that 
they correspond to products having the fatty acyl chain shortened either 
with C13 or C9. To identify the specific structure of these products, LC-MS 
and LC-MS/MS was performed for the [M-2H]2- of each product. 
 
Figure 1: LC-ESI-MS spectra and total ion chromatogram (TIC) from LC-MS profile obtained for CL 
under non-oxidative (a) and oxidative conditions (b). 
Interestingly these CL short chain oxidation products were never reported 
before to be formed during CL oxidation. However, these products formed 
by cleavage of fatty acyl chains were previously observed during 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) oxidation [26-
27], being this an usual process during lipid peroxidation, which 
corroborates the formation of short chain products during CL oxidation. To 
date, only products formed by insertion of oxygen atoms [16], or formed by 
cleavage of the inner glycerol backbone with formation of phosphatidic acid 
and diacylphosphatidyl-hydroxyacetone [28] were mentioned to occur 
during CL oxidation. Oxidation products formed by insertion of oxygen 
atoms were also observed in the present work, but since they have been 
studied, they will not be discussed. 
Structural characterization by LC-MS/MS of these new short chain 
oxidation products were done based in the study of fragmentation pattern 
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of the [M-2H]2-ions, since in the ion trap MS2 mass spectra the informative 
fatty acid anions (RCOO-) are observed. For a better analysis of the 
fragmentation of double charge ions of the oxidation products, 
fragmentation of double charged ion of tetra-linoleoyl CL was previously 
analyzed in the same experimental conditions. The MS/MS spectrum 
obtained is shown in Figure 2. The structure of the product ions resulting 
from the fragmentation CL [M-2H]2- are represented in Scheme 1 and 
includes the product ions [(M-2H)-RCOO-]-, at m/z 1167, formed by the loss 
of fatty acyl anion and the double charged ion [M-2H-R=C=O]2-, at m/z 
592, formed by the loss of fatty acyl as ketene. Other abundant product 
ions are the carboxylate anions, RCOO-, observed at m/z 279, the [M-H]- 
ions of phosphatidic acid (PA), at m/z of 695 (formed due to cleavage 
between the phosphate group and the inner glycerol) and of 
phosphatidylhydroxyacetone (PHA) at m/z of 751, as represented in 
Scheme 1. The ion at m/z 415 is quite abundant and corresponds to the 
loss of RCOOH from the phosphatidic acid (PA), with formation of the ion 
[PA-RCOOH-H]-. In this spectrum we can observe similar fragmentation 
pathways as previously described by Hsu and Turk [29]. 
In this work the authors show that if different fatty acyl chains are 
present in sn-1 (or sn-1’)and sn-2 (or sn-2’) of CL, it is expected to see in 
the MS/MS spectrum of [M-2H]- ion the product ions R2COO
- > R1COO
-, [M-
2H-R2COO
-]- > [M-2H-R1COO
-]- and [M-2H –R2=C=O]
2- > [M-2H –
R1=C=O]
2- [29].  
 
 
Figure 2: ESI-MS spectrum of the double charged ion of tetra-linoleoyl cardiolipin ([M-2H]2- at m/z 
723). 
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Scheme 1: Fragmentation pathways observed in the LC-MS/MS spectrum of the [M-2H]2- ion of tetra-
linoleoyl CL (m/z 723) 
In resume, the [M-2H]2- mass spectrum exhibits three types of products 
ions that are informative of the structure of CL and that will be used for the 
assignment of the CL oxidation products. These product ions are: a) the 
carboxylate anions (RCOO-); b) the phosphatidic acid less one fatty acyl 
chain [PA-RCOOH-H]- and c) loss of the RCOO- yielding the mono-charged 
ion [(M-2H)-RCOO-]-. 
 
Short chain oxidation products with fatty acyl chain shortened with 
C13 carbon length 
Based on the molecular weight, the CL oxidation product observed at m/z 
719, [M-2H]2-, correspond to a modified CL molecule with one C13 
shortened acyl chain, with an carboxylic acid or aldehyde terminal and also 
bearing additional 2 or 3 oxygen atoms, probably in other linoleic fatty acyl 
chains. The oxidative product observed at m/z 691, [M-2H]2-, may 
correspond to CL bearing two modified linoleic fatty acyl chain by β-
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cleavage with formation of two short fatty acyl chain at C13, also with 
terminal carboxylic acid and plus two oxygen atoms. The reconstructed ion 
chromatograms (RIC) obtained for these short chain products in C13, (ions 
at m/z 691 and 719) identified as [M-2H]2-, are shown in Figure 3. The ion 
at m/z 691 elutes only in one peak, suggesting that this oxidation product 
corresponds to only one compound. The ion at m/z 719 elutes in two low 
abundant peaks, meaning that two isomers are present. The LC-MS/MS of 
these precursor ions are shown in Figure 4 and are summarized in Table 1. 
The tandem mass spectra of each of these oxidation products will be 
discussed and presented separately in the following text. 
These oxidation products were formed by initial abstraction of one 
hydrogen atom from the C13, with further uptake of one O2, with formation 
of a peroxyl radical intermediate. This intermediate generates the 
correspondent C13 alkoxyl radical that can undergo cleavage with formation 
of an aldehyde that further oxidize to terminal carboxylic function. These 
shortened chain products are typical of lipid peroxidation [25] and their 
formation was observed under oxidative conditions in PC and PE 
phospholipids [26-27]. The structure of these CL short chain oxidation 
products were confirmed by LC-MS/MS of the correspondent [M-2H]2-. 
 
 
Figure 3: RIC of the [M-2H]2- ions at m/z 691 and 719 
 
Short chain product at m/z 719 
The short chain oxidation product attributed to the ion at m/z 719 elutes 
at 14.1 and 17.2 minutes. The LC-MS/MS spectra (Figure 4 a) obtained at 
the two elution times show different product ions confirming that two 
distinct compounds were separated. The first oxidation product to elute (RT 
14.1min), corresponding to the most polar structure, shows the presence of 
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where R’COO- is the shortened fatty acyl chain with the additional terminal 
carboxylic acid, with C13. In fact, the product ion at m/z 239, attributed to 
carboxylate anion R’COO- of HOOC(CH2)11COOH, corroborates the presence 
of the shortened dicarboxylic acid. The ion at m/z 375 attributed to [PA’-
RCOOH-H]- (Scheme 1) confirms also the presence of the modified fatty 
acyl chain with terminal carboxylic acid in C13 (Scheme 2). Along the 
manuscript the shortened fatty acyl chains will be generally indicated as 
R’COOH, independently of the length of the chain. This oxidation product 
contains two additional oxygen atoms in one of the others fatty acyl chain 
as a peroxyl group, confirmed by the product ion at m/z 311 (RCOO-+2O) 
and the ion at m/z 447, corresponding to the [PA+2O-RCOOH-H]-. The 
presence of the hydroperoxide was inferred by observing the loss of O2 from 
[M-2H]2-, leading to [M-2H-O2]
2-, at m/z 703. Loss of O2 has already been 
observed in hydroperoxide derivatives [30]. Formation of hydroperoxides in 
CL was observed by Kagan et al [16] during CL oxidation, corroborating the 
present outcome. In the LC-MS/MS spectrum it was also possible to see the 
product ions at m/z 279 and 415, confirming the presence of unmodified 
linoleic acid. Altogether, the data allows proposing that this oxidation 
product is CL modified with one short fatty acyl chain in C13, one linoleic 
acid with a hydroperoxy and two non-modified linoleic fatty acyl chains 
((C18:2)2 / (C18:2+OO) / (C12COOH)) (Scheme 3). 
The CL oxidation product that elutes at RT 17.2 minutes, corresponds to 
a less polar compound, thus probably with a C13 fatty acyl chain with a 
terminal aldehyde and the CL modified with plus 3 oxygen atoms. The 
presence of the product ion at m/z 703, formed by loss of O2 from the [M-
2H]- ion confirmed the presence of an hydroperoxy group. Thus this 
oxidation product must have a hydroxy and a hydroperoxy moieties and a 
shortened C13 aldehyde. The question arises where these hydroxyl and 
peroxyl moieties are linked. The presence of abundant ions at m/z 279 and 
the ion at m/z 415 and m/z 1159 [M-2H-RCOO-]- show the presence of at 
least one non-modified linoleic acid. The product ion at m/z 295 (RCOO-+O) 
and the loss of RCOO-+O with formation of the ion [M-2H-(RCOO+O) -]- at 
m/z 1143, as well as the ion at m/z 431 ( 415+16), confirm the presence of 
a hydroxyl linoleoyl. The loss of R´COO-+2O (ion at m/z 1183), due to the 
loss of the shortened fatty acyl moiety with a terminal aldehyde plus two 
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oxygen, and the formation of the carboxylate anion R´COO-+2O at m/z 255 
is indicative of the presence of the hydroperoxy in the shortened C13 
aldehyde. This identification is confirmed by the absence of the carboxylate 
anion of linoleoyl hydroperoxide at m/z 311 (RCOO-+2O) and the absence 
of the ion due to loss of (RCOO-+2O) (expected at m/z 1127). Altogether, 
the data allows proposing that this oxidation product has two non modified 
linoleic acids, one hydroxyl linoleic acid and a short C13 aldehyde with a 
hydroperoxide ((C18:2)2 / (C18:2+O) / (C12:2+OOCHO)) (Scheme 3). 
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Scheme 2 Fragmentation pathways of the [M-2H]2- ion at m/z 719 
 
Short chain product at m/z 691 
The RIC chromatogram of the [M-2H]2- ion at m/z of 691 shows only one 
peak (RT 17.9 minutes), suggesting the elution of only one compound. 
Based on the molecular weight, it seems that this ion has two shortened 
fatty acyl chains and considering the retention time in comparison with the 
ion at m/z 719, we propose that it contains aldehyde terminal in C13, and 
also four additional oxygen atoms (scheme 3). A modified CL with two 
carboxylic moieties with plus two oxygens should elute earlier, due to 
higher polarity conferred by the carboxylic acid. 
The presence of the ion due to loss of O2 (m/z 675 [M-2H-O2]
2-) suggests 
the presence of a hydroperoxide derivative. The product ions observed in the 
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lower mass region of the spectrum, show the RCOO- at m/z 279, and another 
ion, at m/z 255, with similar relative abundance that is attributable to R’COO- 
with C13 shortened with an aldehyde and plus two oxygen atoms. This is 
consistent with the fatty acyl chain with C13 and a terminal aldehyde bearing 
also a hydroperoxide. A small ion at m/z 223 (RCOO- of a C13 aldehyde) may 
be formed by loss of O2 from the ion at m/z 255, since loss of O2 is a 
predominant fragmentation pathway from hydroperoxy derivatives, as 
observed from the previous ion. This confirms the presence of the aldehyde 
bearing hydroperoxy rather than a shortened fatty acyl with a terminal 
carboxylic acid bearing a hydroxy group. Analysis of higher mass region of 
the LC-MS/MS spectrum (Figure 4 c) show the product ions due to loss of a 
non-modified chain (-280Da ) -RCOOH at m/z 1103 and also the ion due to 
loss of R’COO-+2O, (loss of 256 Da) at m/z 1127. These product ions allow 
proposing the formation of an oxidation product of CL with two shortened 
aldehyde with C13 each with a hydroperoxide and two non modified linoleic 
acids (C18:2)2 / (C12+OOCHO)2 (Scheme 3). 
The low abundant ions at m/z 1071 (-RCOO-+2O) and 311 and 293 (311-
H2O), observed in the LC-MS/MS suggested the co-elution of a positional 
isomer, with a linoleoyl-hydroperoxide, a non- modified linoleoyl residue, 
one shortened aldehyde, and a shortened hydroperoxy-aldehyde (C18:2) / 
(C18:2+OO) / (C12CHO) / (C12+OOCHO). 
 
Table 1: Resume of the main product ions observed in the LC-MS/MS spectra of the CL short chain 
oxidation products formed from beta-cleavage of alkoxy intermediates in C13 
 
719(RT=14.1) 
Acid+2O 
719(RT=17.2) 
Aldehyde+3O 
691(RT=17.9) 
2 Aldehyde +4O 
[M-2H-RCOO-]- 1159 1159 1103 
[M-2H-(RCOOH+O)-]- - 1143 - 
[M-2H-(RCOOH+2O)-]- 1127 - 1071 
[M-2H-R’COO-]- 1199 - - 
[M-2H-(R’COOH+2O)-]- - 1183 1127 
[PA-RCOOH-H]- 415 415 - 
[PA+O-(RCOOH)-H]- - 431 - 
[PA+2O-(RCOOH)-H]- 447 - - 
[PA’-RCOOH-H]- 375 - - 
RCOO- 279 279 279 
[RCOO+O]- - 295 - 
[RCOO+2O]- 311 - 311 
R’COO- 239 - 223 
[R’COO+2O]- - 255 255 
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Scheme 3: Short chain products with C13 at m/z 719 and 691 
 
 
Figure 4: LC-MS/MS spectra of the ions at m/z 719. a) RT= 14.1 minutes; b) 17.2 minutes and c) ion at 
m/z 691 with TR=17.9 minutes 
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Short chain oxidation products with fatty acyl chain shortened with 
C9 carbon length  
Interestingly, other short chain compounds, with one linoleic acid 
shortened with C9 length were observed in the LC-MS spectrum, and 
identified as  [M-2H]2- ions at m/z 685, 693 and 701. They showed higher 
relative abundance when compared with the other C13 shortened chains 
oxidation products. During oxidation of other phospholipids, namely 
phosphatidylcholine and phosphatidylethanolamine with a linoleic acid, it 
was observed that the short chain products with C9 were most abundant 
than the ones in C13 [26-27] and these results are consistent with those 
findings.  
The CL oxidation products with C9 chains were analyzed by LC-MS and 
MS/MS in order to identify the specific structure and the presence of 
isomers.  The RIC obtained for these ions at m/z 685, 693 and 701 are 
shown in Figure 5. Observing the RIC for all ions we can verify the 
separation of two compounds with same m/z value, probably one with a 
carboxylic terminal, eluting earlier, and another with an aldehyde terminal 
in C9. A more detailed analysis was conducted using LC-MS/MS, and the 
detailed information for each ion is resumed in Table 2.  
 
 
 
Figure 5: RIC of CL short-chain products with C9; A –m/z  685; B – m/z  693; C – m/z  701 
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Short chain product at m/z of 685 
The ion at m/z 685 may correspond to CL with a carboxylic acid with C9 
plus one oxygen atom in CL or a molecule with a short aldehyde in C9 with 
plus two oxygen atoms. The presence of the two peaks in the LC profile 
suggests that both products were present. In this case, the compound that 
elutes first, at 18.4 minutes may have a carboxylic acid terminal and the 
second compound, eluting at RT 19.5 min has an aldehyde terminal. 
LC-MS/MS obtained for the ion that elute in the first peak (RT 18.4 min) 
(Figure 6a) shows, in the higher mass region, the ions formed by the loss of 
non-modified linoleic acid  at m/z 1091 ([M-2H-RCOO-]-), the ion formed by 
the loss of the shortened acid in C9 at m/z 1183 ([M-2H-R’COO-]-, and the 
ion [AP-R’COOH-H]- at m/z of 323. Altogether, the data allows proposing 
that this oxidation product is CL-(C18:2)2/(C18:2+OH)/(C8COOH). Moreover 
the presence of the ions at m/z 1167 (due to loss of short aldehyde plus 
two oxygen) and at m/z of 339 ([PA’-RCOOH+2O-H]- indicates that another 
isomer co-elute, identified as  CL-(C18:2)2/(C18:2)/(C8+OOCHO), with a C9 
fatty acyl chain with terminal aldehyde bearing an hydroperoxy group. 
The peak at 19.5 shows in the high mass region of the LC-MS/MS 
spectrum (Figure 6b), the ions due to loss of non-modified linoleic acid  at 
m/z 1091, loss of an oxidized linoleic acid with a peroxyl (RCOO+2O) at m/z 
1059 and the loss of the short aldehyde at m/z 1199. Scheme 4 shows the 
fragmentation pathways observed for this ion. In carboxylate anions region 
it is possible to see the ions at m/z 279 and 311, corresponding to RCOO- 
and [RCOO+2O]-, respectively. Other product ions at m/z 307 and 447, 
assigned as [PA’-RCOOH-H]- and [AP+2O-(RCOOH)-H]-, confirms the 
presence of CL with modified fatty acyl chains: 
(C18:2)2/(C18:2+OO)/(C8CHO). 
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m/z 685
[M-2H]2-
m/z 1091
[M-2H-RCOO-]-
m/z 1059
[M-2H-(RCOO-+2O)]-
-(RCOO-+2O)
-RCOO-
m/z 1199
[M-2H-R'COO]-
-(R'COO-)
m/z 447
[PA-RCOOH-H]-
m/z 415
[PA-RCOOH-H]-
m/z 311
RCOO-+2O
m/z 279
RCOO-
m/z 307
[AP-RCOOH-H]-
 
Scheme 4: Fragmentation pathways of the [M-2H]2- ion at m/z 685 with aldehyde terminal in C9 
(TR=19.5min) 
Short chain product at m/z of 693 
This oxidation product elutes in two peaks at RT 16.8 and RT 18.1min.  
Based on the molecular weight and considering that the compound that 
elutes first must be more polar, we propose that the first oxidation product 
to elute has a carboxylic acid terminal in the C9 short fatty acyl chain and 
two additional oxygen atoms in CL and the second to elute may have a C9 
short fatty acyl chain with a terminal carbonyl group with three additional 
oxygen atoms. LC-MS/MS data was used to confirm the structure of these 
CL oxidation products. The LC-MS/MS spectra at those retention times 
show, as major product ion, the product ion corresponding to the loss of a 
neutral with 32Da, which confirm the presence of a hydroperoxy group in 
both molecules. 
In the  LC-MS/MS (Figure 6 c) of the compound that elutes first 
(RT=16.8min) we can observe in the high mass region: the product ion 
corresponding to the losses a non-modified fatty acyl chain [M-2H-RCOO-]- 
at m/z 1107, a product ion formed by loss of a fatty acyl chain with an 
additional oxygen [M-2H-(RCOO+O)-]- at m/z 1091, a product ion formed 
by loss of a fatty acyl chain with two additional oxygens [M-2H-(RCOO+2O)-
]- at m/z 1075 and other ion due to the loss of the short chain fatty acyl 
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chain with a carboxylic acid terminal [M-2H-R’COO-]- at m/z 1199. A low 
abundant ion at m/z of 323, [AP’-RCOOH-H]- , confirms the presence of a 
short chain with carboxylic acid terminal. Knowing that the compound only 
has two additional oxygen atoms the presence of all these ions indicates 
that two isomers co-elute, regarding the oxygen atoms distribution along 
the linoleic acyl chains, thus having an isomer two hydroxy linoleoyl acyl ( 
due to loss of RCOO-+O) and the other one, one peroxy linoleoyl acyl chain 
(due to loss of RCOO-+2O). The anions [RCOO+O]- and [RCOO+2O]- ions at 
m/z 295 and 311 respectively, confirms the presence of two oxidation 
products of the CL (C18:2) / (C18:2+O)2 / (C8COOH) and (C18:2)2 / (C18:2+OO) 
/ (C8COOH) (Scheme 5). 
The compound that elutes later (RT=18.1 minutes), is a less polar 
compound, suggesting the presence of the short chain fatty acyl bearing a 
terminal aldehyde terminal, with three additional oxygen atoms in the CL 
molecule. The LC-MS/MS spectrum (Figure 6 d) shows the product ions 
corresponding to the loss of four fatty acyl moieties: [M-2H-(RCOO)-]- at 
m/z 1107, [M-2H-(RCOO+O)-]- at m/z 1091, [M-2H-(RCOO+2O)-]- at m/z 
1075 and an ion formed by loss of the shortened fatty acyl chain with C9 
and a terminal aldehyde [M-2H-R’COO-]- at m/z 1215. Altogether, the data 
allows proposing that this oxidation product is (C18:2) / (C18:2+O) / 
(C18:2+OO) / (C8CHO). In the lower mass region of this LC-MS/MS spectrum, 
several carboxylate anions corresponding to the non modified and oxidized 
fatty acyl chain were assigned: RCOO-, RCOO-+O and RCOO-+2O at m/z 
279, 295 and 311 respectively. The ion [AP’-RCOOH-H]- at m/z 307 is also 
present, confirming the presence of the C9 short chain with terminal 
aldehyde, providing further evidence to the presence of this oxidation 
product of CL (Scheme 5). 
 
Short chain product at m/z of 701 
The RIC of the ion [M-2H]2- at m/z of 701 (Figure 5 C) shows two distinct 
peaks. Considering the molecular weight and the fact that these ions 
correspond to the presence of an additional oxygen when compared with 
the oxidation products discussed above, it is suggested that the compound 
that elutes first has a C9 short chain with a carboxylic terminal and three 
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additional oxygen in CL and the second should has a C9 short chain 
aldehyde and four additional oxygen atoms in CL. 
For the compound that eluted at RT=16.4 minutes the LC-MS/MS 
spectrum (Figure 6e) shows on the  higher mass region the product ions 
formed by the loss of the fatty acyl moieties, namely [M- 2H-RCOO-]- at m/z 
of 1123, [M-2H-(RCOO+O)-]- at 1107, [M-2H-(RCOO+2O)-]- at m/z 1091 
and loss of short fatty acyl chain as [M-2H-(R’COO-]- at m/z 1215. This 
means that this oxidation product has one fatty acyl non-modified chain, 
one fatty acyl chain with an additional oxygen, one chain with two oxygens 
and one C9 short chain with carboxylic terminal. The carboxylate anion 
observed at m/z 279 (RCOO-) confirms the presence of a non-modified 
chain while the presence of the product ion at m/z 295 (RCOO-+O) confirms 
the presence of a chain with one additional oxygen. The ions at m/z 311 
(RCOO-+2O) and 447 ([AP+2O-(RCOOH)-H]-) corroborate the presence of 
linoleoyl chain with two additional oxygen atoms. Altogether, the data 
allows proposing that this oxidation product is a CL with (C18:2) / (C18:2+O) / 
(C18:2+OO) / (C8COOH) (Scheme 5). 
The analysis of the LC-MS/MS spectrum of the compound eluting at 17.5 
minutes (Figure 6f) shows abundant product ions at m/z 1123 and 1091, 
[M- RCOOH-H]- and [M-(RCOOH+2O)-H]- respectively, indicative of the 
presence of a non-modified chain and a linoleoyl chain with two additional 
oxygens. The ions [M-2H-R’COO-]- at m/z 1231 confirms the presence of the 
short chain C9 with aldehyde terminal. It is also observed the ion [PA+2O-
(RCOOH)-H]- at m/z 447 and the carboxylate anions at m/z 279 (RCOO-), at 
m/z 311 (RCOO-+2O). Therefore the ion [M-2H]2- at m/z of 701 is a CL 
oxidation product with (C18:2) / (C18:2+OO)2 / (C8CHO) (Scheme 5). 
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Table 2: Resume of the main product ions observed in the LC-MS/MS spectra of the CL short chain 
oxidation products formed from beta-cleavage of alkoxy intermediates in C9 
 
685(RT=18.4) 
Acid+O 
685(RT=19.5) 
Aldehyde +2O 
693(RT=16.8) 
Acid+2O 
693(RT=18.1) 
Aldehyde+3O 
701 (RT=16.4) 
Acid+3O 
701(RT=17.5) 
Aldehyde+4O 
[M-2H-RCOO
-
]
- 
1091 1091 1107 1107 1123 1123 
[M-2H-(RCOO
-
+O)
-
]
-
 - - 1091 1091 1107 1107 
[M-2H-(RCOO
-
+2O)
-
]
-
 - 1059 1075 1075 1091 1091 
[M-2H-R’COO
-
]
-
 1183 1199 1199 1215 1215 1231 
[M-2H-(R’COO+O)
-
]
-
 1167 - - - - - 
[PA-R=C=O-H]
-
 - 433 433 - - - 
[PA-RCOOH-H]
-
 415 415 415 - 415 415 
[PA+O-(RCOOH)-H]
-
 - - 431 431 - - 
[PA+2O-(RCOOH)-H]
-
 - 447 447 - 447 447 
[PA’-RCOOH-H]
-
 323 307 323 307 - - 
[AP’+O-(RCOOH)-H]
-
 339 - - - - - 
RCOO
-
 279 279 279 279 279 279 
RCOO
-
+O - - 295 295 295 - 
RCOO
-
+2O - 311 311 311 311 311 
 
 
Scheme 5: Proposed structures for the short chain products with C9 observed at m/z 685, 693 and 701 
and formed during CL oxidation by the hydroxyl radical generated under Fenton reaction conditions. 
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Figure 6: LC-MS/MS spectra of the ions at m/z 685. a) RT= 18.4 min; b) 19.5 min, of the ion at m/z 
693. c) RT=16.8 min d) RT=18.1 min and of the ion at m/z 701. e) RT=16.4min f) RT=17.5 min 
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Identification of short chain oxidation products of CL in 
mitochondria  
It is know that administration of the antibiotic gentamicin induces 
nephrotoxicity and that this adverse effect of the aminoglycosides is 
mediated by activation of mitochondria apoptosis pathways, namely by the 
release of cyt c to the cytosol [9, 11, 31-33]. Cyt c release has an essential 
role in apoptosis and it is considered to be initiated by CL oxidation [3, 34-
35]. However, gentamicin induced nephrotoxicity has also been co-related 
with lipid peroxidation [10]. Based on these findings we studied changes in 
CL found mitochondria’s from rat kidney subjected to a treatment with 
gentamicin. Information was compared with the ones from mitochondria’s of 
rat controls (without treatment).The presence of nephropathy in the sample 
group, after gentamicin administration, was confirmed by the urea and 
creatinine increase in plasma (data not shown).Phospholipids of 
mitochondria were isolated and fractionated by thin layer chromatography. 
The cardiolipin pools were extracted and analyzed by ESI-MS and the 
phospholipids identified were analyzed by ESI-MS/MS. 
 
In Figure 7 it is shown the ESI-MS spectra of the CL from mitochondria 
from control rats and from rat treated with gentamicin. It is possible to see 
as major ions the ions at m/z 1447 [M-H]- and 723 [M-2H]2- (tetra-linoleoyl 
CL). Other cardiolipin molecules were identified but with lower abundance. 
Further analysis of the mass spectra allowed us to confirm the presence of 
CL oxidative species, in the extracts obtained from rats treated with 
gentamicin. The most abundant oxidation products identified as [M-2H]2- 
ions correspond to the tetralineoylCL (the most abundant CL observed in 
the extract from rat control) hydroxyl and peroxyl derivatives at m/z 731 
(723+8) and 739(723+ 16), derived from the oxidation of the most 
abundant CL. Hydroxy and peroxy CL are typical CL oxidation products, as 
reported by Kagan and co-workers [16]. This result evidences the 
occurrence of lipid peroxidation and specifically cardiolipin oxidation, during 
gentamicin induced nephrotoxicity.  
Moreover, in the lower mass region of the spectrum of the CL extract of 
mitochondria from rat treated with gentamicin, we can see new ions at m/z 
685 and 693, which are absent in the spectrum of the control rats. These 
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products have the same m/z values and by LC-MS analysis showed a similar 
retention time (Figure 8) of some of the new short chain products of CL that 
were identified in our model for oxidation of CL molecule and reported 
above. They were identified as being short chain products with C9 
shortened fatty acyl chains. In order to confirm their structure, LC-MS/MS 
was obtained and the LC-MS/MS spectrum of the ion at m/z 685 in Figure 
8a shows the ions at m/z 311, 447, 1059 and 1199 which confirm the 
formation of C9 aldehyde plus a peroxy linoleoyl chain: 
(C18:2)2/(C18:2+OO)/(C8CHO), as previously identified. Also analysis of the 
LC-MS/MS spectrum of the ion at m/z 693 observed in mitochondria CL 
extract (Figure 8b) allow to identify this oxidation product as (C18:2) / 
(C18:2+O) / (C18:2+OO) / (C8CHO), based on  ions at m/z 295, 307, 1075, 
1107 and 1215 observed in the LC-MS/MS spectrum. 
Since the in vivo analysis show that CL oxidation products are formed in 
mitochondria during nephrotoxicity induced by gentamicin, our results 
corroborate that gentamicin induced nephrotoxicity and CL oxidation are 
two correlated events. 
 
Figure 7: ESI-MS spectra obtain from cardiolipin extracted from mitochondria of rats control (a) and 
with treatment with gentamicin (b) 
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Figure 8: LC-MS/MS spectra and RIC chromatograms of the ions at m/z 685 (a) and 693 (b) observed 
in the ESI-MS spectra of cardiolipin from rats treated with gentamicin and attributed to the short chain 
oxidation product of cardiolipin: (C18:2)2/(C18:2+OO)/(C8CHO) and (C18:2) / (C18:2+O) / 
(C18:2+OO) / (C8CHO), respectively. 
 
Conclusions 
 
The short-chain products, formed by reaction with the hydroxyl radical 
with cardiolipin were identified by liquid- chromatography Electrospray 
Tandem Mass Spectrometry. These products comprised CL with one short 
fatty acyl chain containing terminal aldehyde and carboxylic groups, some 
of them were substituted with hydroperoxide groups. Although CL has four 
linoleic fatty acyl chains, major oxidations products have only one chain 
shortened. However, almost all products have an additional hydroperoxide 
in another linoleoyl chain. Based in the previous results, we were able to 
find short chain oxidation products (with C9) in mitochondria isolated from 
kidney rats treated with gentamicin, which could explain the previous 
mitochondrial dysfunctionality observed in these rats. This finding may open 
new perspectives in the identification of specific molecular targets that may 
be helpful in the understanding of the biological process and the discovery 
of new biomarkers of diseases mediated by CL oxidation.  
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Abstract 
The anionic phospholipid cardiolipin is found almost exclusively in the inner 
membrane of mitochondria, playing an important role in energy 
metabolism. Oxidation of CL has been associated with apoptotic events and 
various pathologies. In this study, electrospray mass spectrometry coupled 
with liquid chromatography (LC-ESI-MS) was used to identify tetralinoleoyl-
cardiolipin (TLCL) modifications induced by the OH. radical generated under 
Fenton reaction conditions (H2O2 and Fe
2+). The identified oxidation 
products of TLCL contained 2, 4, 6 and 8 additional oxygen atoms. These 
long chain oxidation products were characterized by LC-ESI-MS/MS as 
double [M-2H]2- and mono charged [M-H]- ions. A detailed analysis of the 
fragmentation pathways of these precursor ions allowed the identification of 
hydroperoxyde derivatives of CL. MS/MS analysis indicate that CL oxidation 
products with 4, 6 and 8 oxygen atoms have one fatty acyl chain bearing 4 
oxygen atoms ([RCOO+4O]-).  Even when the TLCL molecule was oxidized 
by the addition of eight oxygen atoms, one of the acyl chains remains non-
modified and one fatty acyl chain contains three or four oxygen atoms. This 
led us to conclude that under oxidative conditions by the OH. radical, the 
distribution of oxygens/peroxy groups in the CL molecule is not random, 
even when CL has the same fatty acyl chains in all the positions. Using 
mass spectrometry, the oxidation products have been unequivocal assigned, 
which may be useful for their detection in biological samples. 
 
 
Keywords - cardiolipin, LC-MS, oxidation, hydroxyl radical, eletrospray, 
mass spectrometry 
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Introduction 
Cardiolipin (CL) is a dimeric phospholipid with two phosphatidyl moieties 
and four fatty acyl chains. The fatty acyl groups of CL in mammalian tissues 
are almost exclusively 18-carbon fatty acids, the majority of which are 
linoleic acids (tetralinoleoyl-cardiolipin (TLCL)). In the cells, this 
phospholipid is located most exclusively in the mitochondrial inner 
membrane where it is associated with several mitochondrial proteins. In the 
intermembrane mitochondrial space cardiolipin interacts with cytochrome c 
(cyt c), forming a complex CL-cyt c. It was observed that an increase of 
production of hydrogen peroxide in mitochondria, induces the oxidation of  
CL, with formation of hydroperoxy derivatives. These hydroperoxides have 
been associated with the release of cyt c into the cytosol, a key step in the 
cell apoptosis 1-3. TLCL is very susceptible to oxidative damage by reactive 
oxygen species (ROS), due to the presence of polyunsaturated fatty acyl 
chains 4-6. Oxidation of CL has been associated with Barth syndrome, 
thyroid dysfunction, aging, diabetes and also in the pathogenesis of several 
neurodegenerative diseases namely, Parkinson and Alzheimer 7-9. 
Currently there’s a limited knowledge on the nature of the oxidation 
products of CL, even though its relevant biological consequences. In the 
recent years there is an increasing interest in the observation of CL 
modification under oxidative conditions. However this is a challenge, since 
lipid peroxidation, occurring during ROS oxidation, is a chain reaction and 
thus numerous oxidation products may be formed3. These different 
oxidation products may be responsible for distinct biological effects thus 
increasing the relevance  of identifying each specific oxidation product in 
order to understand their specific biological significance and effects 3. 
Mass spectrometry (MS) has been previously used to identify phospholipids 
oxidation products, including cardiolipin’s oxidative products, generated 
during oxidative processes (review on 10). However, few studies have used 
MS to identify the oxidation products of CL. Yurkova, Shadyro and co-
workers using MALDI-MS in positive mode have identified phosphatidic acid 
and diacylphosphatidyl-hydroxyacetone resulting from cleavage of the CL 
molecule in consequence of the oxidative process. In these studies, γ-
radiation, Cu2+/H2O2/ascorbate, or cytochrome c was used to induce 
oxidative modifications on CL11-14.  
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Kagan et al, using  electrospray mass spectrometry (ESI-MS) and tandem 
mass spectrometry (MS/MS) in negative mode, have identified oxidative 
modifications of CL induced by the presence of cytochrome c/H2O2
15, by γ–
irradiation16, after traumatic brain injury6, during staurosporine induced 
apoptosis17 and by pro-inflammatory stimuli using LPS18. In these studies, it 
was noticed the oxidation of CL by accumulation of hydroxy and 
hydroperoxy groups in CL, with the insertion of one to eight oxygen atoms. 
Among these, oxidation products with peroxyl groups were preferentially 
formed. In a more recent study these authors have used tandem mass 
spectrometry to identify and confirm the location of peroxy groups along the 
fatty acyl chain of the CL molecules18. In this important study, the MS/MS 
spectra of oxidation products as [M-H]- of CL plus one and two oxygen 
atoms, and tandem mass spectra of [M-2H]2-  for the CL plus one, two, 
three and four oxygens namely hydroxy and hydroperoxy derivatives, were 
analyzed. However the distribution of the oxygen atoms along the CL 
molecule and fatty acyl chains for the other oxidation products with higher 
number of oxygen atoms was not confirmed by tandem mass spectrometry 
and no previous separation using chromatography techniques were used to 
identify possible isomers. 
In this paper we discuss the identification and structural characterization by 
LC-MS/MS of TLCL long-chain oxidation products, correspondent to the 
addition of two to eight oxygen atoms formed during oxidation using the 
Fenton system. A LC-MS approach was developed and applied to verify the 
presence of isomers. A detailed interpretation of MS/MS spectra will be done 
to identify ions that allow the unequivocal assignment of distribution of 
oxygen atoms in oxidized TLCL. This should provide significant information 
for the detection of these oxidative products in biological samples. 
 
Experimental 
 
Materials  
Tetra-linoleoyl CL was purchased from Sigma and was used without further 
purification. Ferrous chloride and hydrogen peroxide (30%, w/v) were used 
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for oxidation reactions and were obtained from Merck (Darmstadt, 
Germany). Chloroform and methanol used were HPLC grade. 
 
Oxidation of cardiolipin by Fenton reaction 
Ammonium bicarbonate buffer 5mM (pH 7.4) was added to 0.5 mg of CL, 
and the solution was taken to the vortex and the sonicator for the formation 
of vesicles. The oxidation was performed by adding 40µM of FeCl2 and 
50mM of H2O2 to a total volume of 250 µL of solution. The mixture was 
incubated at 37°C in the dark for several hours. Controls were performed by 
replacing hydrogen peroxide with water. 
 
LC-ESI-MS conditions 
The LC-MS and LC-MSn studies were conducted on a Waters Alliance 
(Milford, USA) Model 2690 equipped with a pre-column split (Accurate, LC 
Packings, USA) and an 150×1.0mm i.d. ACE 3 C18-AR column (Advanced 
Chromatography Technologies, Scotland, United Kingdom), kept at room 
temperature (22°C). The reaction mixture was diluted 50 fold before 
injection and a volume of 10 µL was introduced into the column, using a 
flow rate of 25µLmin-1. The phospholipid oxidation products were separated 
using water-methanol (90:10, v/v, eluent A) and methanol (100%, eluent 
B) programmed as follows: a linear increase from 90%B to 100% B in 15 
minutes and held isocratically for 20 min. The mobile phase was brought 
back to the initial elution conditions in 10 min and allowed to equilibrate for 
15 min until the next injection. 
The LXQ linear ion trap mass spectrometer (ThermoFinnigan, San Jose, CA) 
was operated in negative mode. Typical ESI conditions were as follows: 
electrospray voltage was 4.7 kV; capillary temperature was 275°C and the 
sheath gas flow was 25 units. An isolation width of 0.5 Da was used with a 
30 ms activation time for MS/MS experiments. Full scan MS spectra and 
MS/MS spectra were acquired with a 50 ms and 200ms maximum ionization 
time, respectively. Normalized collision energyTM (CE) was varied between 
15 and 20 (arbitrary units) for tandem mass spectrometry. Data acquisition 
was carried out on an Xcalibur data system (V2.0). 
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Results and Discussion 
Oxidation of CL was induced using Fenton reaction conditions (H2O2/Fe
2+), 
as described in the experimental section, and the formation of the oxidation 
products was monitored by direct injection and LC-ESI-MS, in negative 
mode. Both [M-2H]2- and [M-H]- ions of CL and CL oxidation products were 
observed in the ESI-MS spectra. When comparing the ESI-MS spectra 
obtained for the CL after the oxidative reaction (Figure 1b) with the CL in 
the absence of oxidation conditions (Figure 1a) we can observe new [M-
2H]2- and [M-H]- ions correspondent to oxidation products, with higher m/z 
than  TLCL (m/z [M-H]-=1447 and m/z [M-2H]2- =723). These products are 
designated as long chain oxidation products in analogy with the oxidation of 
other phospholipids10. The long-chain oxidation products correspond to the 
insertion of 2, 4, 6 and 8 oxygen atoms are observed as [M-H]- at m/z 
1479, 1511, 1543,  1575 and as [M-2H]2- at m/z 739, 755, 771 and 787, 
respectively. Long chain oxidation products were already identified as 
oxidation products in other phospholipids such as phosphatidylcholines19 
and in phosphatidylethanolamines20. CL long-chain products were identified 
by Kagan et al18. It was found that main oxidation products comprised 
hydroperoxy derivatives even after addition of eight oxygen atoms 
(meaning four hydroperoxy groups linked to CL), although only species with 
2 ([M-H]-) and 4 ([M-2H]2-) additional oxygen atoms were studied, as 
described in the introduction section. 
 
Figure 1: ESI-MS spectra obtained for CL under non-oxidative (a) and oxidative conditions 
(b). 
In order to understand the distribution of oxygen atoms along the TLCL 
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both of [M-H]- and [M-2H]2- oxidation products observed in the LC-ESI-
MS/MS spectra. 
In developing the separation method, we tried to obtain the best possible 
resolution in the shortest period of time. Thus, it was possible to resolve the 
oxidation products containing a different number of atoms of oxygen. 
Nevertheless, the simultaneous separation of the isomers of these oxidation 
products proved to be an impossible task. In fact, the chromatographic 
peaks corresponding to different isomeric forms of a particular oxidation 
product appear as broad bands, containing several peaks not completely 
resolved. However, it was possible to obtain different LC-MS/MS spectra in 
different areas of these chromatographic peaks. As we shall see, these MS / 
MS spectra correspond to different isomers of the oxidation products of CL 
and the information contained therein can be used to uniquely identify these 
products. 
The MS/MS spectrum of the [M-H]- ion of non modified TLCL (m/z 1447) 
can be divided in three distinct zones, as described by Hsu and Turk21-23: 
the phosphatidic acid ([PA-H]-, m/z 695), the [(PA-H)+136]- (m/z 831) and 
the mono phosphatidic acid ([PA-RCOOH]-, m/z 415 ) zone. The structures 
of each ion are found in Figure 2. 
 
Figure 2: LC-MS/MS spectrum of the [M-H]- ion of TLCL at m/z 1447, showing the most 
diagnostic product ions, their m/z values and structures. 
The MS/MS spectrum of the [M-2H]2- ion of non modified CL (m/z 723) 
show two distinct zones:  the carboxylate ion (RCOO-, m/z 279); and the 
[PA-RCOOH]- ion(m/z 415)24. 
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 Long-chain oxidation products of CL analyzed by LC-ESI-MS 
The oxidation products formed by the insertion of two oxygen atoms, elute 
in one peak (RT 23.1min), indicating that, most probably, this is a non-
isomeric oxidation product. In fact, this is in agreement with the previous 
published work by Kagan group that identify this oxidation product as 
hydroperoxy–CL18. The LC-MS/MS spectrum of the ion [M-H]- at m/z 1479 
(Figure 3a), corresponding to the [CL+2O]- molecular ion, shows , in the 
[(PA-H)+136]- zone, the ions at m/z 831 ([(PA-H)+136]-) and 863 ([(PA-
H)+136+2O]-). The [PA-H]- zone shows the same information with the 
presence of the ions at m/z 695 ([PA-H]-) and 727 ([(PA-H)+2O]-). In this 
zone, a fragment ion at m/z 709 is also observed, corresponding to the loss 
of H2O from the hydroperoxy-PA (m/z 727). In the PA-RCOOH zone, both 
the ions at m/z 415 [PA-RCOOH]- and 447 [(PA+2O)-RCOOH]- are present; 
indicating that the two additional oxygen atoms are in the same acyl chain. 
Based on the LC-MS/MS data, the oxidation product of TLCL with two 
oxygen atoms is TLCL-(C18:2)2/(C18:2)(C18:2+OO) (Figure 4). 
 
In order to confirm this information the LC-MS/MS spectrum of the 
molecular ion at m/z 739 ([M-2H]2-, (CL+2O)) was analyzed (figure 3c). 
Carboxylate anions are observed at m/z 279 (RCOO-) and 311  
([RCOO+2O]-), and also the ions m/z 415 and 447, also observed in the 
MS/MS of [M-H]-, confirming the presence of a hydroperoxy CL. 
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Figure 3: (a) RIC of the [M-H]- ion at m/z 1479 and [M-2H]2- ion at m/z 739 of the TLCL plus 
two oxygen atoms. (b) LC-MS/MS of the [M-H]- ion. (c) LC-MS/MS of the [M-2H]2-. 
 
Figure 4: Proposed structure of the ion at m/z 739 (CL+2O)- 
The oxidation product formed by the insertion of four oxygen atoms to 
TLCL, correspondent to the molecular ion at m/z 1511 ([M-H]-) and at m/z 
755 ([M-2H]2-) elutes in two overlapping peaks, at 18.3min and at 19.3min 
(Figure 5a). This suggests the presence of two isomeric structures, 
confirmed by the LC-MS/MS spectra obtained for each retention time. 
The LC-MS/MS of the molecular ion at m/z 1511 ([M-H]-), obtained at RT 
18.3min (Figure 5b) shows the ions at m/z 831 ([(PA-H)+136]-) and 863 
([(PA-H)+136+2O]-). It also shows the ions at m/z 695 ([PA-H]-), 727 
([(PA-H)+2O]-). These product ions indicate that in this oxidation product 
each hydroperoxy group is located in different PA moieties of the TLCL 
molecule. The  LC-MS/MS spectrum of the [M-2H]2- ( Figure 5c)  of the 
isomer that elutes at 18.3min shows the RCOO- fragment ion at m/z 279 
and the [RCOO+2O]- fragment ion at m/z 311, confirming the presence of 
non modified fatty acyl chains and a fatty acyl chain with two additional 
oxygen atoms (hydroperoxy linoleoy fatty acyl chain). The fragment ions 
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PA-RCOOH, observed at m/z 415 and the PA-RCOOH+2O ion, observed at 
m/z 447 confirm this isomer is TLCL-(C18:2)(C18:2+OO)/(C18:2)(C18:2+OO). 
The LC-MS/MS of the molecular ion at m/z 1511 ([M-H]-), obtained at RT 
19.3 (Figure 5b) shows the fragment ions at m/z 831 (([PA-H)+136]-), 863 
([(PA-H)+136+2O]-), and 895 ([(PA-H)+136+4O]-). Also, in the other 
region of this spectrum, we can see the fragment ions at m/z 695 ([PA-H]-), 
727 ([(PA-H)+2O]-) and 759 ([(PA-H)+4O]-). The ions with m/z 759 and 
895, identified as [PA-H]- and [PA+136]- ions with 4 additional oxygen 
atoms, only appear in the LC-MS/MS spectrum obtained at 19.3min, and 
are absent from the MS/MS spectrum of the isomer that elutes at RT 18.3. 
This indicates that this TLCL oxidation product has the 4 oxygen atoms in 
the same PA moiety. Due to the poor chromatographic resolution of these 
two isomers, the ion at m/z 727 (corresponding to PA plus two oxygen 
atoms) is present in both spectra but its presence at oxygen atoms 19.3min 
we due to the tailing of the isomer eluting at 18.3 min. Despite our efforts, 
we were unable to obtain better chromatographic separation. Furthermore, 
the fragment ions at m/z 279 (RCOO-), 311 ([RCOO+2O]-) and 343 
([RCOO+4O]-), corresponding to the non-modified acyl chain, the acyl chain 
with two and with four additional oxygen atoms, are observed in the LC-
MS/MS spectra of the [M-2H]2- molecular ion of the isomer  eluting at 
19.3min. In the [PA-RCOOH]- zone it is also possible to observe the 
fragment ion at m/z 479, corresponding to the [PA-RCOOH]- plus four 
oxygen atoms. This allows us to conclude that the isomer bears the 4 
oxygen atoms in only one fatty acyl chain. As previously noted, the 
observation of the fragment ion at m/z 311 can be due to some co-elution 
of the isomer with RT 18.3. 
Altogether, these results allow us to propose the following structures for 
these compounds: CL-(C18:2)(C18:2+OO)/(C18:2)(C18:2+OO) (RT 18.3min) and 
CL-(C18:2))2/(C18:2) (C18:2+(OO)2) (RT 19.3min) (Figure 6). 
 Interestingly, in a previous study that identified short chain oxidation 
products formed during TLCL oxidation, it was found that multiple oxidation 
occurs in only one fatty acyl chain, while the other three fatty acyl chains 
remain unmodified 25. Also, oxidation in more than one place of linoleoyl 
fatty acyl chain was observed during oxidation of PLPC19. 
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Figure 5: (a)RIC of the [M-H]- ion at m/z 1511 and [M-2H]2- ion at m/z 755 of the CL plus 
four oxygen atoms. (b)LC-MS/MS of the [M-H]- ion. (c) LC-MS/MS of the [M-2H]2- 
Figure 6: Proposed structures for the ion with m/z 1511: a) RT 18.3 min; b) 19.3 min 
 
Long chain CL oxidation products with 6 additional oxygen atoms were also 
analyzed by LC-MS/MS. The RIC obtained for this CL plus six oxygen atoms, 
shows the elution of, at least four isomers, since four overlapping peaks are 
identified in Figure 7a. 
The LC-MS/MS spectrum of the molecular ion at m/z 1543 ([M-H]-) acquired 
at 15.0 and 16.1min are similar (Figure 7b), the most abundant product ion 
is [PA-H+2O]-, at m/z 727. We can also observe the fragment ion at m/z 
863, corresponding to [(PA-H)+136+2O]-. Besides, diagnostic ion of the 
presence of 4 additional oxygen atoms is observed at m/z 895 ([(PA-
H)+136+4O]-). It is important to point out that the ions at m/z 695 and 
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831, corresponding to the non-modified [PA-H]- and [(PA-H)+136]- 
respectively, are of very low abundance. Also, the carboxylate anions 
observed in the LC-MS/MS spectrum of [M-2H]2- acquired at the same RT 
are observed at m/z 279 and 311 ([RCOO+2O]-) and the ions at m/z 295 
([RCOO+O]-), 327 ([RCOO+3O]-) and 343 ([RCOO+4O]-) are absent. With 
these results we propose the following structure for the ion eluting at 
16.3min: CL-(C18:2)(C18:2+OO)/(C18:2+OO)2. 
The LC-MS/MS spectrum of the molecular ion at m/z 1543 ([M-H]-) acquired 
at 17.5min shows the product ions at m/z 727, 743 and 759, corresponding 
respectively to [PA-H]- with 2, 3 and 4 additional oxygen atoms. Fragment 
ions of the zone [(PA-H)+136]- with 2, 3, 4 and 5 additional oxygen atoms 
are observed at m/z 863, 879, 895 and 911. These ions suggest the 
presence of a mixture of positional isomers, as shown in the Figure 8. 
The LC-MS/MS spectrum of the [M-2H]2- obtained at 17.5min, shows the 
fragment ions at m/z 295 ([RCOO+O]-) and 327 ([RCOO+3O]-), as well as 
the ions at m/z 279 (RCOO-) and 311 ([RCOO+2O]-). The fragment ion at 
m/z 295 shows the presence of a hydroxyl fatty acyl chain. The fragment 
ion at m/z 327 shows the presence of an acyl chain with three additional 
oxygen atoms, corresponding to a hydroxyl-hydroperoxy fatty acyl chain. 
Altogether, we propose that this compound should have one non modified 
acyl chain, one chain with an hydroxyl group, one chain with two additional 
oxygen atoms and another chain with three additional oxygen atoms. The  
two isomers that co-elute considering the different distribution of the 
oxidized fatty acyl chains (CL-(C18:2)(C18:2+OO)/ (C18:2+O)(C18:2+3O), CL-
(C18:2)(C18:2+O)/(C18:2+OO)(C18:2+3O)). And are shows in Figure 8. 
The compound(s) with the LC-MS/MS spectrum shown in Figure 7a elutes at 
18.9min; It yields the product ions at m/z 695 ([PA-H]-), 727 ([(PA-
H)+2O]-), 759 ([(PA-H)+4O]-), and 791 ([(PA-H)+6O]-). In the [(PA-
H)+136]- zone, the [(PA-H)+136]- with 2 and 4 additional oxygen atoms are 
observable, due to the presence of the ions at m/z 863 and 895. The 
presence of these ions, as described previously, suggests that mixture of 
positional isomers is co-eluting (Figure 8). The LC-MS/MS spectrum of the 
ion [M-2H]2- shows in carboxylate anions zone the ions at m/z 279 (RCOO-), 
311 ([RCOO+2O]-) and 343 ([RCOO+4O]-) and the spectrum shows in the 
[(PA-H)-RCOOH]- zone, the ions at m/z 415 ([(PA-H)-RCOOH]-), 447 ([(PA-
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H+2O)-RCOOH]-) and 479 ([(PA-H+4O)-RCOOH]-). This data shows that the 
derivatives that elute at 18.9 min possesses two non modified acyl chains 
(m/z 279), one chain with two oxygen atoms (m/z 311) and another with 
four additional oxygen atoms (m/z 343). In conclusion, based in the LC-
MS/MS spectrum of the ions [M-H]- and [M-2H]2- we can affirm that, at 
least, two isomers co-elute: CL-(C18:2)(C18:2+(OO)2)/ (C18:2)(C18:2+OO) and 
CL-(C18:2)2/(C18:2+(OO)2)(C18:2+OO) 
 
 
Figure 7: (a)RIC of the [M-H]- ion at m/z 1543 and [M-2H]2- at m/z 771 attributed to CL plus 
6 oxygen atoms. (b) LC-MS/MS of the [M-H]- ion. (c) LC-MS/MS of the [M-2H]2- ion.  
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Figure 8: proposed structures for the ion with m/z 1543 (TLCL+6O): a) RT 16.1min;b) RT 
17.5min; c) RT 18.9min. 
 
The RIC obtained for the CL oxidation product plus 8 oxygen atoms (Figure 
9a), is a broad peak, probably due to the presence of several isomers. 
However we can observe two distinct LC-MS/MS spectra, one at 13.8min 
and another at 15.6min. 
The LC-MS/MS spectrum of the [M-H]- ion obtained at 13.8min shows, with 
high  relative abundance, the fragment ion at m/z 759, corresponding to 
[PA-H]- with four additional oxygen atoms. The LC-MS/MS spectrum of the 
ion [M-2H]2- shows the ion  [RCOO+4O]- at m/z 343, indicating that one 
acyl chain possesses two additional oxygen atoms and another possesses 
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four additional oxygen atoms The absence in the tandem mass spectra of 
other informative ions lead us proposing the structure in which each peroxy 
group is quantitatively distributed in each linoleic acid chain(CL- 
(C18:2+(OO)2)/ C18:2+(OO)2)) as shown in Figure 10. 
The LC-MS/MS spectrum of the ion [M-H]- obtained at 15.6min (Figure 9a) 
shows ions at m/z 743 ([(PA-H)+3O]-), 759 ([(PA-H)+4O]-), and 775 ([(PA-
H)+5O]-) and [PA+136+5O]- at m/z 911. In the LC-MS/MS the ion [M-2H]2- 
spectrum obtained at 15.6min we can observe the ions at m/z 295, 311 and 
343, correspondent to the RCOO- plus, respectively, 1, 2 and 4 additional 
oxygen atoms in the acyl chains . The presence of the all these product ions 
lead us to conclude that several isomers co-elute in this chromatographic 
peak (RT=15.6min, Figure 9a). However, the identified ions lead us to 
propose the following structures: CL-(C18:2+O)(C18:2+(OO)2)/ 
(C18:2+O)(C18:2+OO) and CL-(C18:2+OO)2/(C18:2)(C18:2+(OO)2) as represented 
in Figure 10. 
 
Figure 9: (a) RIC of the [M-H]- ion at m/z 1575 and [M-2H]2- ion at m/z 787 of the CL plus 
eight oxygen atoms. (b) LC-MS/MS of the [M-H]- ion. (c) LC-MS/MS of the [M-2H]2- . 
a)
b) c)
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Figure 10: Proposed structures for the ion with m/z 1575: a) RT 13.8min; b) 15.6min. 
 
Conclusions 
The long-chain oxidation products, formed by reaction with the hydroxyl 
radical with cardiolipin were identified by liquid-chromatography 
electrospray tandem mass spectrometry. Long chain oxidation products 
formed by the addition of 2, 4, 6 and 8 oxygen atom to CL molecule were 
identified and characterized by reverse phase LC-MS/MS. This approach 
allowed determining the distribution of the oxygen atoms along the CL 
molecule and to separate several isomers of the long chain products with 
higher number of oxygen atoms. It was found that the linoleoyl fatty acyl 
chains TLCL molecule doesn’t oxidize equally. Even when TLCL molecule 
oxidized by the addition of eight oxygen atoms, there is  still  one non-
modified acyl chain and thus another fatty acyl chain with three or four 
oxygen atoms. This means that, under oxidative conditions by the OH., the 
distribution of oxygen atoms/peroxy groups is random in the CL molecule, 
even when CL have equal fatty acyl chains in all the positions. Specific 
product ions of each isomer observed in the MS/MS spectra were identified 
which will be a valuable tool for their detection in biological samples. 
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These findings may open up new perspectives in the identification of specific 
molecular targets that may be helpful in the understanding of the biological 
process and the discovery of new biomarkers of diseases mediated by CL 
oxidation. 
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Conclusions  
 
The oxidation products, formed during the in vitro reaction of the 
hydroxyl radical with cardiolipin, were identified by Liquid- Chromatography 
Electrospray Tandem Mass Spectrometry (LC-MS and MS/MS). The CL 
oxidation products identified comprise long chain products, which are 
products that preserve the phospholipid skeleton and short chain products, 
formed by cleavage of the unsaturated fatty acyl chains. The shortened 
fatty acyl chain contains either a terminal aldehyde or carboxylic groups.  
Although the CL studied has four linoleic fatty acyl chains, major oxidations 
products have only one chain shortened. However, almost all products have 
an additional hydroperoxide in another linoleoyl chain.  
Analysis of biological samples using the same methodology allow the 
identification of CL  short chain oxidation products (with C9) in mitochondria 
isolated from kidney rats  with nephropathy induce by gentamicin, which 
could explain the mitochondrial dysfunctionality observed in these rats. 
 
Long chain oxidation products formed by the addition of 2, 4, 6 and 8 
oxygen atom to CL molecule were also characterized by reverse phase LC-
MS/MS. This approach allows to separate several isomers of the long chain 
products with higher number of oxygens and to identify their distribution 
along the CL fatty acyl chain.  The TLCL molecule doesn’t oxidize the same 
way in all acyl chains. Even a TLCL molecule with eight additional oxygen 
atoms still possesses one non-modified acyl chain. Specific product ions of 
each isomer observed in the MS/MS spectra were identified which will be a 
valuable tool for their detection in biological samples. 
These findings may open up new perspectives in the identification of 
specific molecular targets that may be helpful in the understanding of the 
biological process and the discovery of new biomarkers of diseases 
mediated by CL oxidation. 
